PCQ的个人主页 - 老虎社区

PCQ

PCQ

暂无个人介绍

IP属地：未知

25关注

3粉丝

0主题

0勋章

2021-11-29

okay

抱歉，原内容已删除

2021-11-18

Okay

抱歉，原内容已删除

2021-11-23

Okay

抱歉，原内容已删除

2021-11-19

[Smile]

抱歉，原内容已删除

2021-11-15

Okay!

抱歉，原内容已删除

2021-11-04

interesting

Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen：世卫组织批准科瓦克辛可能会转移投资者的注意力</blockquote>

2021-12-16

[Smile] [Smile]

Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>

2021-11-22

Okay

抱歉，原内容已删除

2021-11-10

okay

抱歉，原内容已删除

2021-11-17

okay

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087463284623270","uuid":"4087463284623270","gmtCreate":1624360404939,"gmtModify":1637631494654,"name":"PCQ","pinyin":"pcq","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":25,"tweetSize":39,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":691559816,"gmtCreate":1640223175185,"gmtModify":1640223175185,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691559816","repostId":"1183786099","repostType":2,"repost":{"id":"1183786099","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640217398,"share":"https://www.laohu8.com/m/news/1183786099?lang=zh_CN&edition=full","pubTime":"2021-12-23 07:56","market":"sh","language":"zh","title":"昨夜今晨：美股指两连涨！特斯拉大涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183786099","media":"老虎资讯综合","summary":"摘要：①纳指涨1.18%，新能源汽车股表现强势，特斯拉大涨7.5%；\n\n\n ②美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓；\n\n\n ③供应链称苹果首款电动车Apple Car将于","content":"<blockquote>\n 摘要：①纳指涨1.18%，新能源汽车股表现强势，特斯拉大涨7.5%；\n</blockquote>\n<blockquote>\n ②美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓；\n</blockquote>\n<blockquote>\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n</blockquote>\n<p></p>\n<p><b>海外市场</b></p>\n<p>1、美股指两连涨！纳指涨超1% 特斯拉大涨7.5%</p>\n<p>美股三大指数集体收涨，主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针，并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%，好于市场预期。截至收盘，纳斯达克指数涨1.18%，标普500指数涨1.02%，道琼斯指数涨0.74%。</p>\n<p>新能源汽车股表现强势，SonoGroup涨近14%；特斯拉收涨7.5%，创11月1日以来最大单日涨幅，市值当日暴增706.21亿美元(约合人民币4498亿元)。</p>\n<p>小鹏汽车涨超4%，理想汽车涨1.4%。大型科技股集体走高，苹果涨1.53%，亚马逊涨0.36%，Meta跌1.12%，谷歌涨2.05%，微软涨1.81%，奈飞涨1.54%。</p>\n<p>2、热门中概股多数收跌 阿里跌超4%</p>\n<p>阿里巴巴跌超4%，此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位</p>\n<p>其他中概股方面，雾芯科技涨超2%，京东微涨；贝壳收平，百度跌近1%，金山云、新东方跌超1%，滴滴跌超6%，好未来跌超3%，搜狐跌超2%。</p>\n<p>3、欧股主要指数上涨，法国CAC40指数涨超1%</p>\n<p>德国DAX30指数收涨0.91%，英国富时100指数涨0.60%，法国CAC40指数涨1.24%，欧洲斯托克50指数涨1.00%。</p>\n<p>4、原油库存降幅超预期 美油收高2.3%</p>\n<p>因美国能源信息署(EIA)报告称美国原油库存降幅超出预期，令油价得到支撑。最终，纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元，涨幅为2.3%，收于每桶72.76美元。</p>\n<p>5、黄金期货收高0.8% 站上1800美元关口</p>\n<p>最近黄金期货多次测试1800美元关口，但未能长时间维持在其上方。但在周三，美元走软和美国国债收益率低迷，帮助金价站上这一关口。</p>\n<p>最终，纽约商品交易所2月交割的黄金期货价格上涨13.50美元，涨幅为0.8%，收于每盎司1802.20美元。</p>\n<p>6、土耳其股市连续4个交易日收跌 22日触发一次熔断</p>\n<p>当地时间22日，土耳其伊斯坦布尔100指数开盘报1.832.14点，较前一日收盘下跌3.14%。当地时间14时39分，股指下跌超5%，触发熔断。随后股指持续震荡，当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。</p>\n<p>分析人士指出，土耳其财政和货币政策的不可预测性，让投资者信心受到影响，在这种情况下，很多投资者可能会选择撤离观望。</p>\n<p>由于总统埃尔多安推动货币宽松政策，土耳其央行9月以来已经累计下调基准利率500个基点，而每次下调都使得里拉进一步贬值，和年初相比，里拉跌幅曾一度超过55%。</p>\n<p><b>国际宏观</b></p>\n<p>1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案</p>\n<p>美国总统乔·拜登表示，他的政府与工会和企业一起成功避免了假日季节的供应链危机。</p>\n<p>“今年秋天的时候，我们听到很多关于供应链问题的可怕警告，声称假日前后会出现危机，”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”</p>\n<p>2、美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓</p>\n<p>美国三季度实际GDP年化季环比终值 2.3%，预期 2.1%，前值 2.1%，是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺，以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。</p>\n<p>3、美国三季度核心PCE物价指数创近30年新高 符合预期</p>\n<p>12月22日周三，据美国商务部统计，美国第三季度核心PCE物价指数年化季环比终值上涨4.6%，略高于4.5%的前值和预期；同比终值上升3.6%，与预期持平，仍是近30年最高水平。</p>\n<p>4、今年美国IPO发行量创下历史纪录 但回报率差强人意</p>\n<p>根据彭博汇编的数据，今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易，不包括更多的特殊目的收购公司，总共创下了约1670亿美元的记录，轻松超越2020年。</p>\n<p>尽管发行金额创下历史新高，但由于波动性和表现不佳，对IPO的热情在年底有所减弱。交易商表示，尽管2022年第一季看起来将十分忙录，但预计未来一年会较为波动。</p>\n<p>5、美国11月二手房销量连续第三个月增长</p>\n<p>美国全国地产经纪商协会周三公布的数据显示，11月二手房销量环比增长1.9%，折合年率达646万套，创下1月以来最大增幅。彭博调查预估中值为6.53万套。</p>\n<p>该数据表明住房需求正在加速上升，尤其是在高端市场，因为贷款成本仍远低于新冠疫情前的水平。即便如此，高房价也可能使一些潜在买家望而却步，尤其是收入水平较低、受通胀打击更大的消费者。</p>\n<p>6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌</p>\n<p>世界大型企业研究会周三的报告显示，消费者信心指数升至115.8，11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。</p>\n<p>数据显示，尽管随着omicron的传播，美国一些地区实施了新的防疫限制措施，但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示，随着美国人对新冠病毒及其变异株的适应性增强，每一波疫情带来的经济影响会变得较小。</p>\n<p>7、世卫组织正在确定第二代新冠疫苗</p>\n<p>世卫组织总干事谭德塞在22日的新闻发布会上透露，世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。</p>\n<p>谭德塞表示，相关研究团队于9月下旬开始招募志愿者，到目前为止，已有超过11500人参加了试验。截至目前，该试验包括两种疫苗，另外三种疫苗不久将被纳入，而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。</p>\n<p>8、美国政府宣布将学生贷款偿还期限延至明年5月1日</p>\n<p>当地时间22日，美国白宫新闻秘书珍·普萨基在简报会上证实，拜登已经宣布将学生贷款的偿还期限延长90天，到明年的5月1日。普萨基说，部分学生贷款的借款人受到新冠肺炎疫情的影响，需要时间偿还。</p>\n<p>9、欧洲能源告急！天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动</p>\n<p>天然气暴涨也让欧洲国家坐不住了。本周三，意大利总理德拉吉在年末新闻发布会上表示，遏制能源短缺亟需采取紧急政策行动：“能源价格上涨需要紧急行动，我们不能等了。”</p>\n<p>同在周三，英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称，英国的议员感到恐慌，可能为保护国内家庭而寻求设定电费上限。</p>\n<p>10、联合国安理会投票通过为阿富汗提供人道援助的决议</p>\n<p>当地时间22日，联合国安理会一致通过决议，向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示，中方支持联合国发挥更大协调作用，呼吁所有国际伙伴加大对阿援助力度，并解除对阿制裁。</p>\n<p><b>公司新闻</b></p>\n<p>1、<a href=\"https://laohu8.com/NW/2193115827\" target=\"_blank\">特斯拉股价一度大涨逾8% 市值重返1万亿美元上方</a></p>\n<p>特斯拉股价周三一度大涨逾8%，助其市值重返1万亿美元上方，此前该公司CEO埃隆•马斯克在接受采访时透露，他已完成了出售10%所持特斯拉股票的目标。</p>\n<p>Wedbush分析师Dan Ives评价道，在经历了几周的黑暗后，特斯拉终于迎来了好消息，马斯克的这一声明消除了对特斯拉股价的威胁，抛售压力和负面看法问题已经解决，投资者重新关注华尔街的基本面驱动因素。</p>\n<p>2、<a href=\"https://laohu8.com/NW/2193116621\" target=\"_blank\">苹果汽车早产！供应链称Apple Car将于明年9月发布</a></p>\n<p>12月2日消息，有媒体报道称，苹果首款电动车「Apple Car」有望将提前问世。此前，外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过，国内供应链大厂董座直言，苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露，随着订单出货、组装完成，Apple Car 首款原型车，已有数十辆秘密在美国加州上路测试中，预计出货量与商机将会在明年初显，2022 年全面爆发。</p>\n<p>3、<a href=\"https://laohu8.com/NW/2193172113\" target=\"_blank\">辉瑞新冠口服药获美国FDA紧急授权</a></p>\n<p>当地时间22日，辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权，可以用于治疗出现轻度至中度症状的新冠肺炎患者。</p>\n<p>4、<a href=\"https://laohu8.com/NW/2193118492\" target=\"_blank\">美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查</a></p>\n<p>知情人士透露，美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。</p>\n<p>FTC主席Lina Khan一直是亚马逊的批评者，正在推进前任主席几年前启动的一项调查。</p>\n<p>亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际，Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授，在反垄断界大名鼎鼎，一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：美股指两连涨！特斯拉大涨超7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：美股指两连涨！特斯拉大涨超7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-23 07:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n 摘要：①纳指涨1.18%，新能源汽车股表现强势，特斯拉大涨7.5%；\n</blockquote>\n<blockquote>\n ②美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓；\n</blockquote>\n<blockquote>\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n</blockquote>\n<p></p>\n<p><b>海外市场</b></p>\n<p>1、美股指两连涨！纳指涨超1% 特斯拉大涨7.5%</p>\n<p>美股三大指数集体收涨，主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针，并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%，好于市场预期。截至收盘，纳斯达克指数涨1.18%，标普500指数涨1.02%，道琼斯指数涨0.74%。</p>\n<p>新能源汽车股表现强势，SonoGroup涨近14%；特斯拉收涨7.5%，创11月1日以来最大单日涨幅，市值当日暴增706.21亿美元(约合人民币4498亿元)。</p>\n<p>小鹏汽车涨超4%，理想汽车涨1.4%。大型科技股集体走高，苹果涨1.53%，亚马逊涨0.36%，Meta跌1.12%，谷歌涨2.05%，微软涨1.81%，奈飞涨1.54%。</p>\n<p>2、热门中概股多数收跌 阿里跌超4%</p>\n<p>阿里巴巴跌超4%，此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位</p>\n<p>其他中概股方面，雾芯科技涨超2%，京东微涨；贝壳收平，百度跌近1%，金山云、新东方跌超1%，滴滴跌超6%，好未来跌超3%，搜狐跌超2%。</p>\n<p>3、欧股主要指数上涨，法国CAC40指数涨超1%</p>\n<p>德国DAX30指数收涨0.91%，英国富时100指数涨0.60%，法国CAC40指数涨1.24%，欧洲斯托克50指数涨1.00%。</p>\n<p>4、原油库存降幅超预期 美油收高2.3%</p>\n<p>因美国能源信息署(EIA)报告称美国原油库存降幅超出预期，令油价得到支撑。最终，纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元，涨幅为2.3%，收于每桶72.76美元。</p>\n<p>5、黄金期货收高0.8% 站上1800美元关口</p>\n<p>最近黄金期货多次测试1800美元关口，但未能长时间维持在其上方。但在周三，美元走软和美国国债收益率低迷，帮助金价站上这一关口。</p>\n<p>最终，纽约商品交易所2月交割的黄金期货价格上涨13.50美元，涨幅为0.8%，收于每盎司1802.20美元。</p>\n<p>6、土耳其股市连续4个交易日收跌 22日触发一次熔断</p>\n<p>当地时间22日，土耳其伊斯坦布尔100指数开盘报1.832.14点，较前一日收盘下跌3.14%。当地时间14时39分，股指下跌超5%，触发熔断。随后股指持续震荡，当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。</p>\n<p>分析人士指出，土耳其财政和货币政策的不可预测性，让投资者信心受到影响，在这种情况下，很多投资者可能会选择撤离观望。</p>\n<p>由于总统埃尔多安推动货币宽松政策，土耳其央行9月以来已经累计下调基准利率500个基点，而每次下调都使得里拉进一步贬值，和年初相比，里拉跌幅曾一度超过55%。</p>\n<p><b>国际宏观</b></p>\n<p>1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案</p>\n<p>美国总统乔·拜登表示，他的政府与工会和企业一起成功避免了假日季节的供应链危机。</p>\n<p>“今年秋天的时候，我们听到很多关于供应链问题的可怕警告，声称假日前后会出现危机，”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”</p>\n<p>2、美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓</p>\n<p>美国三季度实际GDP年化季环比终值 2.3%，预期 2.1%，前值 2.1%，是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺，以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。</p>\n<p>3、美国三季度核心PCE物价指数创近30年新高 符合预期</p>\n<p>12月22日周三，据美国商务部统计，美国第三季度核心PCE物价指数年化季环比终值上涨4.6%，略高于4.5%的前值和预期；同比终值上升3.6%，与预期持平，仍是近30年最高水平。</p>\n<p>4、今年美国IPO发行量创下历史纪录 但回报率差强人意</p>\n<p>根据彭博汇编的数据，今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易，不包括更多的特殊目的收购公司，总共创下了约1670亿美元的记录，轻松超越2020年。</p>\n<p>尽管发行金额创下历史新高，但由于波动性和表现不佳，对IPO的热情在年底有所减弱。交易商表示，尽管2022年第一季看起来将十分忙录，但预计未来一年会较为波动。</p>\n<p>5、美国11月二手房销量连续第三个月增长</p>\n<p>美国全国地产经纪商协会周三公布的数据显示，11月二手房销量环比增长1.9%，折合年率达646万套，创下1月以来最大增幅。彭博调查预估中值为6.53万套。</p>\n<p>该数据表明住房需求正在加速上升，尤其是在高端市场，因为贷款成本仍远低于新冠疫情前的水平。即便如此，高房价也可能使一些潜在买家望而却步，尤其是收入水平较低、受通胀打击更大的消费者。</p>\n<p>6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌</p>\n<p>世界大型企业研究会周三的报告显示，消费者信心指数升至115.8，11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。</p>\n<p>数据显示，尽管随着omicron的传播，美国一些地区实施了新的防疫限制措施，但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示，随着美国人对新冠病毒及其变异株的适应性增强，每一波疫情带来的经济影响会变得较小。</p>\n<p>7、世卫组织正在确定第二代新冠疫苗</p>\n<p>世卫组织总干事谭德塞在22日的新闻发布会上透露，世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。</p>\n<p>谭德塞表示，相关研究团队于9月下旬开始招募志愿者，到目前为止，已有超过11500人参加了试验。截至目前，该试验包括两种疫苗，另外三种疫苗不久将被纳入，而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。</p>\n<p>8、美国政府宣布将学生贷款偿还期限延至明年5月1日</p>\n<p>当地时间22日，美国白宫新闻秘书珍·普萨基在简报会上证实，拜登已经宣布将学生贷款的偿还期限延长90天，到明年的5月1日。普萨基说，部分学生贷款的借款人受到新冠肺炎疫情的影响，需要时间偿还。</p>\n<p>9、欧洲能源告急！天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动</p>\n<p>天然气暴涨也让欧洲国家坐不住了。本周三，意大利总理德拉吉在年末新闻发布会上表示，遏制能源短缺亟需采取紧急政策行动：“能源价格上涨需要紧急行动，我们不能等了。”</p>\n<p>同在周三，英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称，英国的议员感到恐慌，可能为保护国内家庭而寻求设定电费上限。</p>\n<p>10、联合国安理会投票通过为阿富汗提供人道援助的决议</p>\n<p>当地时间22日，联合国安理会一致通过决议，向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示，中方支持联合国发挥更大协调作用，呼吁所有国际伙伴加大对阿援助力度，并解除对阿制裁。</p>\n<p><b>公司新闻</b></p>\n<p>1、<a href=\"https://laohu8.com/NW/2193115827\" target=\"_blank\">特斯拉股价一度大涨逾8% 市值重返1万亿美元上方</a></p>\n<p>特斯拉股价周三一度大涨逾8%，助其市值重返1万亿美元上方，此前该公司CEO埃隆•马斯克在接受采访时透露，他已完成了出售10%所持特斯拉股票的目标。</p>\n<p>Wedbush分析师Dan Ives评价道，在经历了几周的黑暗后，特斯拉终于迎来了好消息，马斯克的这一声明消除了对特斯拉股价的威胁，抛售压力和负面看法问题已经解决，投资者重新关注华尔街的基本面驱动因素。</p>\n<p>2、<a href=\"https://laohu8.com/NW/2193116621\" target=\"_blank\">苹果汽车早产！供应链称Apple Car将于明年9月发布</a></p>\n<p>12月2日消息，有媒体报道称，苹果首款电动车「Apple Car」有望将提前问世。此前，外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过，国内供应链大厂董座直言，苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露，随着订单出货、组装完成，Apple Car 首款原型车，已有数十辆秘密在美国加州上路测试中，预计出货量与商机将会在明年初显，2022 年全面爆发。</p>\n<p>3、<a href=\"https://laohu8.com/NW/2193172113\" target=\"_blank\">辉瑞新冠口服药获美国FDA紧急授权</a></p>\n<p>当地时间22日，辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权，可以用于治疗出现轻度至中度症状的新冠肺炎患者。</p>\n<p>4、<a href=\"https://laohu8.com/NW/2193118492\" target=\"_blank\">美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查</a></p>\n<p>知情人士透露，美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。</p>\n<p>FTC主席Lina Khan一直是亚马逊的批评者，正在推进前任主席几年前启动的一项调查。</p>\n<p>亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际，Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授，在反垄断界大名鼎鼎，一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183786099","content_text":"摘要：①纳指涨1.18%，新能源汽车股表现强势，特斯拉大涨7.5%；\n\n\n ②美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓；\n\n\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n\n\n海外市场\n1、美股指两连涨！纳指涨超1% 特斯拉大涨7.5%\n美股三大指数集体收涨，主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针，并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%，好于市场预期。截至收盘，纳斯达克指数涨1.18%，标普500指数涨1.02%，道琼斯指数涨0.74%。\n新能源汽车股表现强势，SonoGroup涨近14%；特斯拉收涨7.5%，创11月1日以来最大单日涨幅，市值当日暴增706.21亿美元(约合人民币4498亿元)。\n小鹏汽车涨超4%，理想汽车涨1.4%。大型科技股集体走高，苹果涨1.53%，亚马逊涨0.36%，Meta跌1.12%，谷歌涨2.05%，微软涨1.81%，奈飞涨1.54%。\n2、热门中概股多数收跌 阿里跌超4%\n阿里巴巴跌超4%，此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位\n其他中概股方面，雾芯科技涨超2%，京东微涨；贝壳收平，百度跌近1%，金山云、新东方跌超1%，滴滴跌超6%，好未来跌超3%，搜狐跌超2%。\n3、欧股主要指数上涨，法国CAC40指数涨超1%\n德国DAX30指数收涨0.91%，英国富时100指数涨0.60%，法国CAC40指数涨1.24%，欧洲斯托克50指数涨1.00%。\n4、原油库存降幅超预期 美油收高2.3%\n因美国能源信息署(EIA)报告称美国原油库存降幅超出预期，令油价得到支撑。最终，纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元，涨幅为2.3%，收于每桶72.76美元。\n5、黄金期货收高0.8% 站上1800美元关口\n最近黄金期货多次测试1800美元关口，但未能长时间维持在其上方。但在周三，美元走软和美国国债收益率低迷，帮助金价站上这一关口。\n最终，纽约商品交易所2月交割的黄金期货价格上涨13.50美元，涨幅为0.8%，收于每盎司1802.20美元。\n6、土耳其股市连续4个交易日收跌 22日触发一次熔断\n当地时间22日，土耳其伊斯坦布尔100指数开盘报1.832.14点，较前一日收盘下跌3.14%。当地时间14时39分，股指下跌超5%，触发熔断。随后股指持续震荡，当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。\n分析人士指出，土耳其财政和货币政策的不可预测性，让投资者信心受到影响，在这种情况下，很多投资者可能会选择撤离观望。\n由于总统埃尔多安推动货币宽松政策，土耳其央行9月以来已经累计下调基准利率500个基点，而每次下调都使得里拉进一步贬值，和年初相比，里拉跌幅曾一度超过55%。\n国际宏观\n1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案\n美国总统乔·拜登表示，他的政府与工会和企业一起成功避免了假日季节的供应链危机。\n“今年秋天的时候，我们听到很多关于供应链问题的可怕警告，声称假日前后会出现危机，”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”\n2、美国三季度实际GDP年化季环比终值 2.3%，较二季度增速大幅放缓\n美国三季度实际GDP年化季环比终值 2.3%，预期 2.1%，前值 2.1%，是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺，以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。\n3、美国三季度核心PCE物价指数创近30年新高 符合预期\n12月22日周三，据美国商务部统计，美国第三季度核心PCE物价指数年化季环比终值上涨4.6%，略高于4.5%的前值和预期；同比终值上升3.6%，与预期持平，仍是近30年最高水平。\n4、今年美国IPO发行量创下历史纪录 但回报率差强人意\n根据彭博汇编的数据，今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易，不包括更多的特殊目的收购公司，总共创下了约1670亿美元的记录，轻松超越2020年。\n尽管发行金额创下历史新高，但由于波动性和表现不佳，对IPO的热情在年底有所减弱。交易商表示，尽管2022年第一季看起来将十分忙录，但预计未来一年会较为波动。\n5、美国11月二手房销量连续第三个月增长\n美国全国地产经纪商协会周三公布的数据显示，11月二手房销量环比增长1.9%，折合年率达646万套，创下1月以来最大增幅。彭博调查预估中值为6.53万套。\n该数据表明住房需求正在加速上升，尤其是在高端市场，因为贷款成本仍远低于新冠疫情前的水平。即便如此，高房价也可能使一些潜在买家望而却步，尤其是收入水平较低、受通胀打击更大的消费者。\n6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌\n世界大型企业研究会周三的报告显示，消费者信心指数升至115.8，11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。\n数据显示，尽管随着omicron的传播，美国一些地区实施了新的防疫限制措施，但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示，随着美国人对新冠病毒及其变异株的适应性增强，每一波疫情带来的经济影响会变得较小。\n7、世卫组织正在确定第二代新冠疫苗\n世卫组织总干事谭德塞在22日的新闻发布会上透露，世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。\n谭德塞表示，相关研究团队于9月下旬开始招募志愿者，到目前为止，已有超过11500人参加了试验。截至目前，该试验包括两种疫苗，另外三种疫苗不久将被纳入，而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。\n8、美国政府宣布将学生贷款偿还期限延至明年5月1日\n当地时间22日，美国白宫新闻秘书珍·普萨基在简报会上证实，拜登已经宣布将学生贷款的偿还期限延长90天，到明年的5月1日。普萨基说，部分学生贷款的借款人受到新冠肺炎疫情的影响，需要时间偿还。\n9、欧洲能源告急！天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动\n天然气暴涨也让欧洲国家坐不住了。本周三，意大利总理德拉吉在年末新闻发布会上表示，遏制能源短缺亟需采取紧急政策行动：“能源价格上涨需要紧急行动，我们不能等了。”\n同在周三，英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称，英国的议员感到恐慌，可能为保护国内家庭而寻求设定电费上限。\n10、联合国安理会投票通过为阿富汗提供人道援助的决议\n当地时间22日，联合国安理会一致通过决议，向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示，中方支持联合国发挥更大协调作用，呼吁所有国际伙伴加大对阿援助力度，并解除对阿制裁。\n公司新闻\n1、特斯拉股价一度大涨逾8% 市值重返1万亿美元上方\n特斯拉股价周三一度大涨逾8%，助其市值重返1万亿美元上方，此前该公司CEO埃隆•马斯克在接受采访时透露，他已完成了出售10%所持特斯拉股票的目标。\nWedbush分析师Dan Ives评价道，在经历了几周的黑暗后，特斯拉终于迎来了好消息，马斯克的这一声明消除了对特斯拉股价的威胁，抛售压力和负面看法问题已经解决，投资者重新关注华尔街的基本面驱动因素。\n2、苹果汽车早产！供应链称Apple Car将于明年9月发布\n12月2日消息，有媒体报道称，苹果首款电动车「Apple Car」有望将提前问世。此前，外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过，国内供应链大厂董座直言，苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露，随着订单出货、组装完成，Apple Car 首款原型车，已有数十辆秘密在美国加州上路测试中，预计出货量与商机将会在明年初显，2022 年全面爆发。\n3、辉瑞新冠口服药获美国FDA紧急授权\n当地时间22日，辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权，可以用于治疗出现轻度至中度症状的新冠肺炎患者。\n4、美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查\n知情人士透露，美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。\nFTC主席Lina Khan一直是亚马逊的批评者，正在推进前任主席几年前启动的一项调查。\n亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际，Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授，在反垄断界大名鼎鼎，一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690069678,"gmtCreate":1639614219904,"gmtModify":1639614219904,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690069678","repostId":"1194155872","repostType":4,"repost":{"id":"1194155872","kind":"news","pubTimestamp":1639613035,"share":"https://www.laohu8.com/m/news/1194155872?lang=zh_CN&edition=full","pubTime":"2021-12-16 08:03","market":"us","language":"en","title":"Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194155872","media":"RTTNews","summary":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day sli","content":"<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次下跌，此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于3,115点的高位，尽管预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>在FOMC货币政策会议结果公布后，全球对亚洲市场的预测乐观。欧洲和美国市场稳步走高，亚洲股市预计也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>在房地产和工业股下跌后，海指周三小幅收低，而金融股则涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天，该指数在3,106.63点至3,120.55点之间交易后，下跌6.21点或0.20%，收于3,114.88点。成交量为8.834亿股，价值7.618亿新元。下跌股264家，上涨股180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌0.34%，凯德综合商业信托下跌0.50%，City Developments下跌0.42%，Comfort DelGro上涨1.45%，Dairy Farm International暴跌2.42%，星展集团上涨0.19%，云顶新加坡退保0.64%，吉宝企业下跌0.39%，丰树商业信托下跌0.98%，丰树物流信托下跌0.53%，华侨银行下跌0.27%，胜科工业下跌0.51%，新加坡航空下跌0.20%，新加坡电信下跌0.41%，泰国饮料下跌0.75%，大华银行下跌0.15%，丰益国际下跌0.96%，扬子江造船、新加坡报业控股、新加坡科技工程和新天科技持平。</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的，主要股指周三开盘小幅走低，但随后下午飙升，收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&amp;P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点，涨幅1.08%，收于35,927.43点；纳斯达克指数飙升327.94点，涨幅2.15%，收于15,565.58点；标普500指数上涨75.76点，涨幅1.63%，收于4,709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>在美联储宣布了人们普遍预期的加快缩减资产购买计划步伐的决定后，华尔街尾盘上涨。美联储以通胀发展和劳动力市场进一步改善为由表示，已决定将净资产购买速度每月减少300亿美元，是此前宣布的每月150亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示，预计每个月净资产购买速度的类似减少可能是适当的，这表明该计划将于明年3月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时，美联储还宣布了广泛预期的决定，将联邦基金利率目标区间维持在零至0.25%。与9月份的一次加息预测相比，央行的最新预测2022年将加息多达三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息时间可能早于预期，但分析师表示，交易员对美联储最新预测提供的确定性水平提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署（EIA）表示，上周美国原油库存减少460万桶，原油期货周三收高。西德克萨斯中质原油1月期货收涨0.14美元或0.2%，报每桶70.87美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-16 08:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次下跌，此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于3,115点的高位，尽管预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>在FOMC货币政策会议结果公布后，全球对亚洲市场的预测乐观。欧洲和美国市场稳步走高，亚洲股市预计也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>在房地产和工业股下跌后，海指周三小幅收低，而金融股则涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天，该指数在3,106.63点至3,120.55点之间交易后，下跌6.21点或0.20%，收于3,114.88点。成交量为8.834亿股，价值7.618亿新元。下跌股264家，上涨股180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌0.34%，凯德综合商业信托下跌0.50%，City Developments下跌0.42%，Comfort DelGro上涨1.45%，Dairy Farm International暴跌2.42%，星展集团上涨0.19%，云顶新加坡退保0.64%，吉宝企业下跌0.39%，丰树商业信托下跌0.98%，丰树物流信托下跌0.53%，华侨银行下跌0.27%，胜科工业下跌0.51%，新加坡航空下跌0.20%，新加坡电信下跌0.41%，泰国饮料下跌0.75%，大华银行下跌0.15%，丰益国际下跌0.96%，扬子江造船、新加坡报业控股、新加坡科技工程和新天科技持平。</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的，主要股指周三开盘小幅走低，但随后下午飙升，收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&amp;P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点，涨幅1.08%，收于35,927.43点；纳斯达克指数飙升327.94点，涨幅2.15%，收于15,565.58点；标普500指数上涨75.76点，涨幅1.63%，收于4,709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>在美联储宣布了人们普遍预期的加快缩减资产购买计划步伐的决定后，华尔街尾盘上涨。美联储以通胀发展和劳动力市场进一步改善为由表示，已决定将净资产购买速度每月减少300亿美元，是此前宣布的每月150亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示，预计每个月净资产购买速度的类似减少可能是适当的，这表明该计划将于明年3月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时，美联储还宣布了广泛预期的决定，将联邦基金利率目标区间维持在零至0.25%。与9月份的一次加息预测相比，央行的最新预测2022年将加息多达三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息时间可能早于预期，但分析师表示，交易员对美联储最新预测提供的确定性水平提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署（EIA）表示，上周美国原油库存减少460万桶，原油期货周三收高。西德克萨斯中质原油1月期货收涨0.14美元或0.2%，报每桶70.87美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194155872","content_text":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.\nThe global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.\nThe STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.\nFor the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.\nAmong the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.\nThe lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.\nThe Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.\nThe late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.\nThe Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.\nMeanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.\nDespite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":4177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605267036,"gmtCreate":1639182635685,"gmtModify":1639182635685,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[What]&nbsp;","listText":"[What]&nbsp;","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605267036","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=zh_CN&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p><p><blockquote>疫苗股早盘下跌。Moderna、BioNTech和Novavax跌幅在2%至11%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading<blockquote>疫苗股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-10 22:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p><p><blockquote>疫苗股早盘下跌。Moderna、BioNTech和Novavax跌幅在2%至11%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1,"symbols_score_info":{"MRNA":0.9,"BNTX":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606427974,"gmtCreate":1638922262420,"gmtModify":1638922262420,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606427974","repostId":"1159685639","repostType":4,"repost":{"id":"1159685639","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638888367,"share":"https://www.laohu8.com/m/news/1159685639?lang=zh_CN&edition=full","pubTime":"2021-12-07 22:46","market":"us","language":"en","title":"Apple shares rose more than 3% to a new high<blockquote>苹果股价上涨超过3%，创下新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1159685639","media":"Tiger Newspress","summary":"Apple shares rose more than 3% to a new high after the company got another street-high target on vir","content":"<p>Apple shares rose more than 3% to a new high&nbsp;after&nbsp;the&nbsp;company&nbsp;got another street-high target on virtual reality boost.</p><p><blockquote>苹果股价上涨超过3%，创下新高，此前该公司因虚拟现实提振而再次获得华尔街高点。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple Inc.&nbsp;got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p><p><blockquote>苹果公司获得了第二个华尔街最高价目标，因为摩根士丹利认为该公司受益于虚拟现实和自动驾驶汽车的新产品类别。</blockquote></p><p> Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p><p><blockquote>对苹果·跑赢大盘进行评级的分析师凯蒂·休伯蒂(Katy Huberty)将目标价从164美元上调至200美元，与彭博社追踪的目标中韦德布什(Wedbush)持平。</blockquote></p><p> While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p><p><blockquote>尽管考虑到这家iPhone制造商的保密性，投资者一直难以评估该公司的新产品，但休伯蒂预计增强现实和虚拟现实以及自动驾驶汽车最终将被定价，并表示苹果也应该从科技股的“向高质量发展”中受益。</blockquote></p><p> “Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p><p><blockquote>休伯蒂在一份报告中写道：“尽管随着时间的推移，新产品和服务带来了持续且实质性的收入贡献，但苹果股价似乎并未受到即将推出的新产品的影响。”“我们相信，随着苹果在明年推出AR/VR产品，这种情况将会改变。”</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p><p><blockquote>苹果股价今年已飙升25%，周一收盘创下新纪录。投资者认为，在日益动荡的市场中，这家科技巨头是一个安全的赌注，因为该行业估值最高的公司受到了美联储鹰派信号的打击。</blockquote></p><p> Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p><p><blockquote>Huberty还上调了对苹果12月份季度的预期，理由是随着制造中断的缓解，iPhone供应有所改善。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose more than 3% to a new high<blockquote>苹果股价上涨超过3%，创下新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose more than 3% to a new high<blockquote>苹果股价上涨超过3%，创下新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-07 22:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple shares rose more than 3% to a new high&nbsp;after&nbsp;the&nbsp;company&nbsp;got another street-high target on virtual reality boost.</p><p><blockquote>苹果股价上涨超过3%，创下新高，此前该公司因虚拟现实提振而再次获得华尔街高点。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Apple Inc.&nbsp;got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p><p><blockquote>苹果公司获得了第二个华尔街最高价目标，因为摩根士丹利认为该公司受益于虚拟现实和自动驾驶汽车的新产品类别。</blockquote></p><p> Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p><p><blockquote>对苹果·跑赢大盘进行评级的分析师凯蒂·休伯蒂(Katy Huberty)将目标价从164美元上调至200美元，与彭博社追踪的目标中韦德布什(Wedbush)持平。</blockquote></p><p> While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p><p><blockquote>尽管考虑到这家iPhone制造商的保密性，投资者一直难以评估该公司的新产品，但休伯蒂预计增强现实和虚拟现实以及自动驾驶汽车最终将被定价，并表示苹果也应该从科技股的“向高质量发展”中受益。</blockquote></p><p> “Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p><p><blockquote>休伯蒂在一份报告中写道：“尽管随着时间的推移，新产品和服务带来了持续且实质性的收入贡献，但苹果股价似乎并未受到即将推出的新产品的影响。”“我们相信，随着苹果在明年推出AR/VR产品，这种情况将会改变。”</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p><p><blockquote>苹果股价今年已飙升25%，周一收盘创下新纪录。投资者认为，在日益动荡的市场中，这家科技巨头是一个安全的赌注，因为该行业估值最高的公司受到了美联储鹰派信号的打击。</blockquote></p><p> Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p><p><blockquote>Huberty还上调了对苹果12月份季度的预期，理由是随着制造中断的缓解，iPhone供应有所改善。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159685639","content_text":"Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.\n\nApple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.\nAnalyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. \nWhile investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.\n“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”\n\nApple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.\nHuberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606310868,"gmtCreate":1638833792463,"gmtModify":1638833792463,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606310868","repostId":"1191828969","repostType":2,"repost":{"id":"1191828969","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638792831,"share":"https://www.laohu8.com/m/news/1191828969?lang=zh_CN&edition=full","pubTime":"2021-12-06 20:13","market":"us","language":"en","title":"Grab shares slid more than 4% in premarket trading<blockquote>Grab股价在盘前交易中下跌超过4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191828969","media":"Tiger Newspress","summary":"Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.","content":"<p>Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.</p><p><blockquote>Grab股价在盘前交易中下跌超过4%。这家新加坡网约车公司上周开始出售。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares slid more than 4% in premarket trading<blockquote>Grab股价在盘前交易中下跌超过4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares slid more than 4% in premarket trading<blockquote>Grab股价在盘前交易中下跌超过4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 20:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Grab shares slid more than 4% in premarket trading.The&nbsp;Singapore ride-hailing firm&nbsp;went on sale last week.</p><p><blockquote>Grab股价在盘前交易中下跌超过4%。这家新加坡网约车公司上周开始出售。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191828969","content_text":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","news_type":1,"symbols_score_info":{"GRAB":0.9}},"isVote":1,"tweetType":1,"viewCount":3396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608147410,"gmtCreate":1638672022759,"gmtModify":1638672022759,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Sad]&nbsp;","listText":"[Sad]&nbsp;","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608147410","repostId":"1115309845","repostType":4,"repost":{"id":"1115309845","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638541913,"share":"https://www.laohu8.com/m/news/1115309845?lang=zh_CN&edition=full","pubTime":"2021-12-03 22:31","market":"us","language":"en","title":"Stocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨，结束了因奥密克戎担忧引发的动荡一周</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115309845","media":"Tiger Newspress","summary":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the marke","content":"<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p><p><blockquote>周五早盘，股市上涨，回顾了令人失望的11月份就业报告，市场即将结束由新冠奥密克戎变种发展推动的过山车周。</blockquote></p><p> The Dow Jones Industrial Average rose about 100 points. The S&amp;P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p><p><blockquote>道琼斯工业平均指数上涨约100点。标普500上涨0.43%，以科技股为主的纳斯达克综合指数上涨0.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> RLX Technology stock tumbled 6%&nbsp;as&nbsp;its&nbsp;Q3&nbsp;<b>Net revenues</b>&nbsp;decreased by 34%.</p><p><blockquote>RLX科技股价第三季度下跌6%<b>净收入</b>下降34%。</blockquote></p><p> Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p><p><blockquote>在发布好于预期的盈利报告和前景后，Marvell Technology股价飙升20%。</blockquote></p><p> DocuSign shares tumbled 35% on Weak Sales Forecast.</p><p><blockquote>由于销售预测疲软，DocuSign股价暴跌35%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨，结束了因奥密克戎担忧引发的动荡一周</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks gain on Friday to close out volatile week triggered by omicron fears<blockquote>周五股市上涨，结束了因奥密克戎担忧引发的动荡一周</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 22:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p><p><blockquote>周五早盘，股市上涨，回顾了令人失望的11月份就业报告，市场即将结束由新冠奥密克戎变种发展推动的过山车周。</blockquote></p><p> The Dow Jones Industrial Average rose about 100 points. The S&amp;P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p><p><blockquote>道琼斯工业平均指数上涨约100点。标普500上涨0.43%，以科技股为主的纳斯达克综合指数上涨0.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> RLX Technology stock tumbled 6%&nbsp;as&nbsp;its&nbsp;Q3&nbsp;<b>Net revenues</b>&nbsp;decreased by 34%.</p><p><blockquote>RLX科技股价第三季度下跌6%<b>净收入</b>下降34%。</blockquote></p><p> Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p><p><blockquote>在发布好于预期的盈利报告和前景后，Marvell Technology股价飙升20%。</blockquote></p><p> DocuSign shares tumbled 35% on Weak Sales Forecast.</p><p><blockquote>由于销售预测疲软，DocuSign股价暴跌35%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115309845","content_text":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.\nThe Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.\n\nRLX Technology stock tumbled 6% as its Q3 Net revenues decreased by 34%.\nMarvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.\nDocuSign shares tumbled 35% on Weak Sales Forecast.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603593459,"gmtCreate":1638422373223,"gmtModify":1638422373401,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603593459","repostId":"1143092770","repostType":4,"repost":{"id":"1143092770","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638370804,"share":"https://www.laohu8.com/m/news/1143092770?lang=zh_CN&edition=full","pubTime":"2021-12-01 23:00","market":"us","language":"en","title":"Apple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%，创新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1143092770","media":"Tiger Newspress","summary":"Apple shares rose nearly 2% to a new high in morning trading.\nNeedham analyst Laura Martin said inve","content":"<p>Apple shares rose nearly 2% to a new high&nbsp;in morning trading.</p><p><blockquote>苹果股价在早盘交易中上涨近2%，创下新高。</blockquote></p><p> <b>Needham</b>&nbsp;analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.</p><p><blockquote><b>李约瑟</b>分析师Laura Martin表示，投资者转向苹果是因为其庞大的现金流能够渡过难关，不会破产，也不会陷入财务困境。</blockquote></p><p> Martin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.</p><p><blockquote>Martin表示，有迹象表明，苹果目前的产品，尤其是iPhone Pro机型，销售良好，可能会导致该公司12月份季度业绩大增。</blockquote></p><p> Tablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.</p><p><blockquote>马丁补充说，平板电脑，尤其是高端iPhone，都表示今年第四季度将拥有高利润率和高收入。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/edc1b3fcbf75cefc8acb5fa15512530b\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%，创新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose nearly 2% to a new high<blockquote>苹果股价上涨近2%，创新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-01 23:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple shares rose nearly 2% to a new high&nbsp;in morning trading.</p><p><blockquote>苹果股价在早盘交易中上涨近2%，创下新高。</blockquote></p><p> <b>Needham</b>&nbsp;analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.</p><p><blockquote><b>李约瑟</b>分析师Laura Martin表示，投资者转向苹果是因为其庞大的现金流能够渡过难关，不会破产，也不会陷入财务困境。</blockquote></p><p> Martin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.</p><p><blockquote>Martin表示，有迹象表明，苹果目前的产品，尤其是iPhone Pro机型，销售良好，可能会导致该公司12月份季度业绩大增。</blockquote></p><p> Tablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.</p><p><blockquote>马丁补充说，平板电脑，尤其是高端iPhone，都表示今年第四季度将拥有高利润率和高收入。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/edc1b3fcbf75cefc8acb5fa15512530b\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143092770","content_text":"Apple shares rose nearly 2% to a new high in morning trading.\nNeedham analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.\nMartin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.\nTablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":2519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609716514,"gmtCreate":1638325513244,"gmtModify":1638325513244,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609716514","repostId":"1129769141","repostType":4,"repost":{"id":"1129769141","kind":"news","pubTimestamp":1638317199,"share":"https://www.laohu8.com/m/news/1129769141?lang=zh_CN&edition=full","pubTime":"2021-12-01 08:06","market":"us","language":"en","title":"Oversold Singapore Bourse Called Lower Again<blockquote>超卖的新加坡证券交易所再次下调</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1129769141","media":"RTTNews","summary":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 point","content":"<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p><p><blockquote>新加坡股市连续六个交易日收低，跌幅近200点，跌幅6.4%。海峡时报指数目前略高于3,040点的高位，周三的交易再次小幅领先。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p><p><blockquote>对亚洲市场的全球预测表明，对新冠肺炎的持续担忧和对利率前景的担忧将会巩固。欧洲和美国市场下跌，亚洲市场预计也将以类似的方式开盘。</blockquote></p><p> The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p><p><blockquote>海指周二大幅收低，全线受损，尤其是金融和工业股。</blockquote></p><p> For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p><p><blockquote>当天，该指数暴跌79.29点，跌幅2.54%，收于3,041.29点的日低，此前曾触及3,129.54点。成交量为32.2亿股，价值38.9亿新元。下跌股338家，上涨股172家。</blockquote></p><p> Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌2.34%，凯德综合商业信托和怡和周期均下跌1.40%，城市发展上涨0.29%，舒适德尔高暴跌4.20%，乳业国际和泰国饮料均下跌2.19%，星展集团下跌2.99%，云顶新加坡下跌2.53%，吉宝企业下跌2.11%，丰树商业信托下跌2.39%，丰树物流信托下跌1.87%，华侨银行下跌3.17%，胜科工业下跌4.08%，新加坡航空下跌0.81%，新加坡科技工程下跌0.78%，新加坡电信下跌2.07%，丰益国际下跌1.91%，扬子江造船持平。</blockquote></p><p> The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p><p><blockquote>华尔街的领先优势普遍为负面，主要股指周二开盘走低，整个交易日基本保持在水下。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oversold Singapore Bourse Called Lower Again<blockquote>超卖的新加坡证券交易所再次下调</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOversold Singapore Bourse Called Lower Again<blockquote>超卖的新加坡证券交易所再次下调</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-01 08:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p><p><blockquote>新加坡股市连续六个交易日收低，跌幅近200点，跌幅6.4%。海峡时报指数目前略高于3,040点的高位，周三的交易再次小幅领先。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p><p><blockquote>对亚洲市场的全球预测表明，对新冠肺炎的持续担忧和对利率前景的担忧将会巩固。欧洲和美国市场下跌，亚洲市场预计也将以类似的方式开盘。</blockquote></p><p> The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p><p><blockquote>海指周二大幅收低，全线受损，尤其是金融和工业股。</blockquote></p><p> For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p><p><blockquote>当天，该指数暴跌79.29点，跌幅2.54%，收于3,041.29点的日低，此前曾触及3,129.54点。成交量为32.2亿股，价值38.9亿新元。下跌股338家，上涨股172家。</blockquote></p><p> Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌2.34%，凯德综合商业信托和怡和周期均下跌1.40%，城市发展上涨0.29%，舒适德尔高暴跌4.20%，乳业国际和泰国饮料均下跌2.19%，星展集团下跌2.99%，云顶新加坡下跌2.53%，吉宝企业下跌2.11%，丰树商业信托下跌2.39%，丰树物流信托下跌1.87%，华侨银行下跌3.17%，胜科工业下跌4.08%，新加坡航空下跌0.81%，新加坡科技工程下跌0.78%，新加坡电信下跌2.07%，丰益国际下跌1.91%，扬子江造船持平。</blockquote></p><p> The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p><p><blockquote>华尔街的领先优势普遍为负面，主要股指周二开盘走低，整个交易日基本保持在水下。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C6L.SI":"新加坡航空公司","D05.SI":"星展集团控股","STI.SI":"富时新加坡海峡指数","BVA.SI":"顶级手套有限公司","O39.SI":"华侨银行"},"source_url":"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129769141","content_text":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.\nThe global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.\nThe STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.\nFor the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.\nAmong the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.","news_type":1,"symbols_score_info":{"C6L.SI":0.9,"D05.SI":0.9,"O39.SI":0.9,"BVA.SI":0.9,"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":3972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600657865,"gmtCreate":1638150179895,"gmtModify":1638150179895,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600657865","repostId":"1114522326","repostType":4,"isVote":1,"tweetType":1,"viewCount":2887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170549,"gmtCreate":1637628510437,"gmtModify":1637628510437,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"interesting&nbsp;","listText":"interesting&nbsp;","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875170549","repostId":"1144786882","repostType":4,"repost":{"id":"1144786882","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637627337,"share":"https://www.laohu8.com/m/news/1144786882?lang=zh_CN&edition=full","pubTime":"2021-11-23 08:28","market":"us","language":"en","title":"Can Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周收盘价能否突破历史高点？期权分析</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144786882","media":"Benzinga","summary":"What Happened:Apple Inc is having a volatile day, initially up over 2.5% but having since lost all o","content":"<p><b>What Happened:Apple Inc</b>&nbsp;is having a volatile day, initially up over 2.5%&nbsp;but having since lost all of those gains over the last two hours of trading.</p><p><blockquote><b>发生了什么：苹果公司</b>这一天波动较大，最初上涨超过2.5%，但此后在过去两个小时的交易中失去了所有涨幅。</blockquote></p><p> Trading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.</p><p><blockquote>当天交易活动强劲，交易量超过1.04亿股，而10天平均水平为7800万股。最近尾盘的抛售可能是由于亚洲即将到来的假日购物季的供应限制。</blockquote></p><p> But what is fascinating is the heavy level of options activity in the stock today with&nbsp;<b>over 2.73 million contracts traded on the day</b>&nbsp;(see below).</p><p><blockquote>但令人着迷的是，今天该股的期权活动水平很高<b>当日成交逾273万张合约</b>（见下文）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1a3445e396564690250472543787b2dd\" tg-width=\"1002\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>Why It Matters:</b>Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent&nbsp;<b>a massive 36% increase in options in one day.</b></p><p><blockquote><b>为什么重要：</b>周一之前，苹果拥有约410万份评级和330万份看跌期权，总计740万份期权。因此，今天的270多万个期权代表<b>期权在一天内大幅增加了36%。</b></blockquote></p><p> Any time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.</p><p><blockquote>每当一只股票在一天内交易量占期权总数的36%时，就表明期权交易者对该股票非常活跃。考虑到73%的期权交易是评级，这表明期权交易者有强烈的看涨偏见。</blockquote></p><p> <b>What's Next:</b>&nbsp;About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).</p><p><blockquote><b>下一步是什么：</b>今天大约一半的期权流是短期的（周五到期），最集中的执行价格在160美元至170美元之间（如下图）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fdaae290e3e5538e2f6697fe9cbc40e9\" tg-width=\"1105\" tg-height=\"319\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.</p><p><blockquote>短期评级表明期权交易者本周的目标区间在160美元至170美元之间。然而，随着收盘时的强劲抛售，该股可能会跌破160美元。</blockquote></p><p> If Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.</p><p><blockquote>如果苹果跌破160美元水平，则未平仓合约将跌至155美元，但大幅跌破该水平，因此任何低于该水平的大幅波动都可能代表该股出现更大的抛售。</blockquote></p><p> Meanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.</p><p><blockquote>与此同时，如果该股能够突破略高于165美元的历史高点，则有可能上涨至175美元水平。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周收盘价能否突破历史高点？期权分析</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Close Above The All-Time Highs This Week? Option Analysis<blockquote>苹果本周收盘价能否突破历史高点？期权分析</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-11-23 08:28</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>What Happened:Apple Inc</b>&nbsp;is having a volatile day, initially up over 2.5%&nbsp;but having since lost all of those gains over the last two hours of trading.</p><p><blockquote><b>发生了什么：苹果公司</b>这一天波动较大，最初上涨超过2.5%，但此后在过去两个小时的交易中失去了所有涨幅。</blockquote></p><p> Trading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.</p><p><blockquote>当天交易活动强劲，交易量超过1.04亿股，而10天平均水平为7800万股。最近尾盘的抛售可能是由于亚洲即将到来的假日购物季的供应限制。</blockquote></p><p> But what is fascinating is the heavy level of options activity in the stock today with&nbsp;<b>over 2.73 million contracts traded on the day</b>&nbsp;(see below).</p><p><blockquote>但令人着迷的是，今天该股的期权活动水平很高<b>当日成交逾273万张合约</b>（见下文）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1a3445e396564690250472543787b2dd\" tg-width=\"1002\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>Why It Matters:</b>Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent&nbsp;<b>a massive 36% increase in options in one day.</b></p><p><blockquote><b>为什么重要：</b>周一之前，苹果拥有约410万份评级和330万份看跌期权，总计740万份期权。因此，今天的270多万个期权代表<b>期权在一天内大幅增加了36%。</b></blockquote></p><p> Any time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.</p><p><blockquote>每当一只股票在一天内交易量占期权总数的36%时，就表明期权交易者对该股票非常活跃。考虑到73%的期权交易是评级，这表明期权交易者有强烈的看涨偏见。</blockquote></p><p> <b>What's Next:</b>&nbsp;About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).</p><p><blockquote><b>下一步是什么：</b>今天大约一半的期权流是短期的（周五到期），最集中的执行价格在160美元至170美元之间（如下图）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fdaae290e3e5538e2f6697fe9cbc40e9\" tg-width=\"1105\" tg-height=\"319\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.</p><p><blockquote>短期评级表明期权交易者本周的目标区间在160美元至170美元之间。然而，随着收盘时的强劲抛售，该股可能会跌破160美元。</blockquote></p><p> If Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.</p><p><blockquote>如果苹果跌破160美元水平，则未平仓合约将跌至155美元，但大幅跌破该水平，因此任何低于该水平的大幅波动都可能代表该股出现更大的抛售。</blockquote></p><p> Meanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.</p><p><blockquote>与此同时，如果该股能够突破略高于165美元的历史高点，则有可能上涨至175美元水平。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144786882","content_text":"What Happened:Apple Inc is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.\nTrading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.\nBut what is fascinating is the heavy level of options activity in the stock today with over 2.73 million contracts traded on the day (see below).\n\nWhy It Matters:Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent a massive 36% increase in options in one day.\nAny time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.\nWhat's Next: About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).\n\nThe short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.\nIf Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.\nMeanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":4006,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170061,"gmtCreate":1637628442357,"gmtModify":1637628442357,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875170061","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":1690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872766499,"gmtCreate":1637576322119,"gmtModify":1637576322119,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872766499","repostId":"2185826772","repostType":4,"isVote":1,"tweetType":1,"viewCount":1014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876175969,"gmtCreate":1637286640802,"gmtModify":1637286640802,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876175969","repostId":"1168345410","repostType":4,"isVote":1,"tweetType":1,"viewCount":1120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878226325,"gmtCreate":1637199210060,"gmtModify":1637199210060,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878226325","repostId":"1180752156","repostType":4,"isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871759657,"gmtCreate":1637115093499,"gmtModify":1637115101793,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871759657","repostId":"1185179037","repostType":4,"isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664166,"gmtCreate":1636939001730,"gmtModify":1636939001730,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay!","listText":"Okay!","text":"Okay!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664166","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879457626,"gmtCreate":1636767229986,"gmtModify":1636767229986,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"interesting&nbsp;","listText":"interesting&nbsp;","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879457626","repostId":"1163118124","repostType":4,"isVote":1,"tweetType":1,"viewCount":878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879230715,"gmtCreate":1636727014411,"gmtModify":1636727014411,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay nice","listText":"Okay nice","text":"Okay nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879230715","repostId":"1104158261","repostType":4,"isVote":1,"tweetType":1,"viewCount":1157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847697615,"gmtCreate":1636511453772,"gmtModify":1636511453902,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay&nbsp;","listText":"okay&nbsp;","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847697615","repostId":"1179672442","repostType":4,"isVote":1,"tweetType":1,"viewCount":728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844155652,"gmtCreate":1636413228442,"gmtModify":1636413228916,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844155652","repostId":"1190184675","repostType":4,"repost":{"id":"1190184675","kind":"news","pubTimestamp":1636384600,"share":"https://www.laohu8.com/m/news/1190184675?lang=zh_CN&edition=full","pubTime":"2021-11-08 23:16","market":"us","language":"en","title":"Buffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190184675","media":"Bloomberg","summary":"(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire","content":"<p>(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.</p><p><blockquote>（彭博社）——随着亿万富翁投资者沃伦·巴菲特继续抛售，他对股市飙升表示谨慎。</blockquote></p><p> Buffett’s Berkshire Hathaway Inc. was a net seller of equities for the fourth straight quarter, a trend not seen in data going back to 2008. The company ended up selling almost $2 billion more in stocks than it purchased during the period, adding to a cash pile that climbed to a record $149.2 billion.</p><p><blockquote>巴菲特的伯克希尔哈撒韦公司连续第四个季度成为股票净卖家，这一趋势在2008年的数据中从未出现过。该公司最终出售的股票比在此期间购买的股票多了近20亿美元，现金储备攀升至创纪录的1,492亿美元。</blockquote></p><p> The selling streak indicates Buffett has struggled to find bargains with the stock market hitting all-time highs. A big, splashy acquisition also eluded the conglomerate, as the 91-year old and his investing deputies confronted a combination of sky-high price tags and fierce competition from the wave of special purpose acquisition companies.</p><p><blockquote>连续抛售表明，随着股市创下历史新高，巴菲特一直在努力寻找便宜货。由于这位91岁的老人和他的投资副手面临着天价标签和来自特殊目的收购公司浪潮的激烈竞争，该集团也未能进行一次引人注目的大型收购。</blockquote></p><p> “The big issue here is that Berkshire was a net seller of stocks again this quarter,” Jim Shanahan, an analyst with Edward Jones, said in a telephone interview. “That’s the primary culprit” of the cash pile continuing to rise.</p><p><blockquote>爱德华·琼斯(Edward Jones)分析师吉姆·沙纳汉(Jim Shanahan)在接受电话采访时表示：“最大的问题是，伯克希尔本季度再次成为股票净卖家。”“这是现金储备持续上升的罪魁祸首”。</blockquote></p><p> Berkshire’s sales appear to have largely come from cutting holdings in banks, insurance and financial investments, according to its third-quarter regulatory filing released Saturday. Berkshire has been paring certain stocks in recent periods, spending the second quarter trimming its investment in General Motors Co. and pulling back on some of its pharmaceutical bets. The company is set to release its third-quarter stock tweaks later this month.</p><p><blockquote>根据伯克希尔周六发布的第三季度监管文件，伯克希尔的销售额似乎主要来自于削减银行、保险和金融投资的持股。伯克希尔哈撒韦公司最近一直在削减某些股票，第二季度削减了对通用汽车公司的投资，并撤回了部分制药押注。该公司将于本月晚些时候发布第三季度股票调整。</blockquote></p><p> While Buffett’s been a consistent net seller these past four quarters, those sales have been relatively small compared with the massive size of his stock portfolio. Over the past nine months, he’s sold almost $7 billion more of stocks than he’s bought, roughly 2.2% of the fair value of Berkshire’s stock portfolio at the end of September.</p><p><blockquote>尽管巴菲特在过去四个季度一直是净卖家，但与他庞大的股票投资组合规模相比，这些销售额相对较小。在过去的九个月里，他卖出的股票比买入的多了近70亿美元，约占伯克希尔9月底股票投资组合公允价值的2.2%。</blockquote></p><p> Buffett warned investors in May that Berkshire might not have much luck striking deals as SPACs gripped the market -- though he also predicted the boom probably wouldn’t last. Compounding the challenge, his most recent big acquisition, the $37 billion deal for Precision Castparts five years ago, resulted in a writedown that Buffett laid squarely at his own door.</p><p><blockquote>巴菲特在5月份警告投资者，随着SPAC席卷市场，伯克希尔哈撒韦公司在达成交易方面可能运气不佳，尽管他也预测这种繁荣可能不会持续下去。让挑战变得更加复杂的是，他最近的一次重大收购，即五年前以370亿美元收购Precision Castparts的交易，导致了巴菲特直接将其记入了自己的账户。</blockquote></p><p> Berkshire isn’t alone in extending a cash pile amid the pandemic. Amazon.com Inc., Google-parent Alphabet Inc. and American Airlines Group Inc. were among companies that amassed significant holdings during the health crisis in a step analysts have said would likely lead to some acquisitions.</p><p><blockquote>伯克希尔并不是唯一一家在疫情期间增加现金储备的公司。亚马逊公司、谷歌母公司Alphabet公司和美国航空集团公司等公司在健康危机期间增持了大量股份，分析师表示，此举可能会导致一些收购。</blockquote></p><p> And the rising cash pile is better than the alternative in the eyes of investors including Cheviot Value Management’s Darren Pollock. Even though Buffett’s cash pile still increased to a record despite the $7.6 billion of buybacks in the third quarter, Pollock says it’s a good sign about the health of Berkshire.</p><p><blockquote>在包括Cheviot Value Management的达伦·波洛克(Darren Pollock)在内的投资者看来，不断增加的现金储备比其他选择更好。尽管第三季度回购了76亿美元，但巴菲特的现金储备仍增至创纪录水平，波洛克表示，这是伯克希尔健康状况的一个好迹象。</blockquote></p><p> “We’re happy with it because the alternative is that cash isn’t growing as much and that means that Berkshire’s operating companies aren’t of as high quality as we thought,” said Pollock, whose Cheviot owns shares in Berkshire. “To see that the cash is rising, to see that he’s deploying so much in one avenue which happens to be buybacks -- it’s not acquisitions -- but it’s being spent in a productive way, it’s so much better than the alternative of seeing that cash stabilize or decline without other large acquisitions.”</p><p><blockquote>波洛克表示：“我们对此感到满意，因为另一种选择是现金没有增长那么多，这意味着伯克希尔哈撒韦公司的运营公司质量没有我们想象的那么高。”波洛克的切维奥特拥有伯克希尔哈撒韦公司的股份。“看到现金在增加，看到他在一个恰好是回购的途径上部署了如此多的资金——而不是收购——但这些资金是以富有成效的方式使用的，这比看到现金的替代方案要好得多如果没有其他大型收购，现金就会稳定或下降。”</blockquote></p><p> Here are some other key takeaways from Berkshire’s third-quarter earnings on Saturday:</p><p><blockquote>以下是伯克希尔周六第三季度财报的其他一些关键要点：</blockquote></p><p> Berkshire Appetite</p><p><blockquote>伯克希尔的胃口</blockquote></p><p> Buffett has increasingly leaned on share buybacks as one way to deploy billions of dollars. He’s spent about $51 billion on stock buybacks since a policy tweak in 2018, outpacing the $31 billion used to purchase shares of Apple Inc., Berkshire’s largest stock bet.</p><p><blockquote>巴菲特越来越依赖股票回购作为部署数十亿美元的一种方式。自2018年政策调整以来，伯克希尔在股票回购上花费了约510亿美元，超过了用于购买苹果股票的310亿美元，这是伯克希尔最大的股票赌注。</blockquote></p><p> In the third quarter, Berkshire bought back $7.6 billion of stock, surpassing the $6 billion of shares repurchased in the previous period.</p><p><blockquote>第三季度，伯克希尔回购了76亿美元的股票，超过了上一期回购的60亿美元股票。</blockquote></p><p> BNSF’s Record</p><p><blockquote>BNSF的记录</blockquote></p><p> Record profit at Berkshire’s railroad, BNSF, and strong earnings from its energy businesses helped raise operating profit by 18% at the conglomerate during the third quarter.</p><p><blockquote>伯克希尔旗下铁路公司BNSF创纪录的利润及其能源业务的强劲收益帮助该集团第三季度的营业利润提高了18%。</blockquote></p><p> That also aided in offsetting a painful quarter for Berkshire’s insurers. Those businesses reported an underwriting loss that widened to $784 million amid heightened catastrophe costs and worsening claims trends at auto insurer Geico.</p><p><blockquote>这也有助于抵消伯克希尔保险公司痛苦的季度。这些企业报告称，由于汽车保险公司Geico的灾难成本增加和索赔趋势恶化，承保损失扩大至7.84亿美元。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett Signals Caution With Berkshire on Stock-Selling Streak<blockquote>巴菲特对伯克希尔哈撒韦公司连续抛售股票表示谨慎</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-11-08 23:16</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.</p><p><blockquote>（彭博社）——随着亿万富翁投资者沃伦·巴菲特继续抛售，他对股市飙升表示谨慎。</blockquote></p><p> Buffett’s Berkshire Hathaway Inc. was a net seller of equities for the fourth straight quarter, a trend not seen in data going back to 2008. The company ended up selling almost $2 billion more in stocks than it purchased during the period, adding to a cash pile that climbed to a record $149.2 billion.</p><p><blockquote>巴菲特的伯克希尔哈撒韦公司连续第四个季度成为股票净卖家，这一趋势在2008年的数据中从未出现过。该公司最终出售的股票比在此期间购买的股票多了近20亿美元，现金储备攀升至创纪录的1,492亿美元。</blockquote></p><p> The selling streak indicates Buffett has struggled to find bargains with the stock market hitting all-time highs. A big, splashy acquisition also eluded the conglomerate, as the 91-year old and his investing deputies confronted a combination of sky-high price tags and fierce competition from the wave of special purpose acquisition companies.</p><p><blockquote>连续抛售表明，随着股市创下历史新高，巴菲特一直在努力寻找便宜货。由于这位91岁的老人和他的投资副手面临着天价标签和来自特殊目的收购公司浪潮的激烈竞争，该集团也未能进行一次引人注目的大型收购。</blockquote></p><p> “The big issue here is that Berkshire was a net seller of stocks again this quarter,” Jim Shanahan, an analyst with Edward Jones, said in a telephone interview. “That’s the primary culprit” of the cash pile continuing to rise.</p><p><blockquote>爱德华·琼斯(Edward Jones)分析师吉姆·沙纳汉(Jim Shanahan)在接受电话采访时表示：“最大的问题是，伯克希尔本季度再次成为股票净卖家。”“这是现金储备持续上升的罪魁祸首”。</blockquote></p><p> Berkshire’s sales appear to have largely come from cutting holdings in banks, insurance and financial investments, according to its third-quarter regulatory filing released Saturday. Berkshire has been paring certain stocks in recent periods, spending the second quarter trimming its investment in General Motors Co. and pulling back on some of its pharmaceutical bets. The company is set to release its third-quarter stock tweaks later this month.</p><p><blockquote>根据伯克希尔周六发布的第三季度监管文件，伯克希尔的销售额似乎主要来自于削减银行、保险和金融投资的持股。伯克希尔哈撒韦公司最近一直在削减某些股票，第二季度削减了对通用汽车公司的投资，并撤回了部分制药押注。该公司将于本月晚些时候发布第三季度股票调整。</blockquote></p><p> While Buffett’s been a consistent net seller these past four quarters, those sales have been relatively small compared with the massive size of his stock portfolio. Over the past nine months, he’s sold almost $7 billion more of stocks than he’s bought, roughly 2.2% of the fair value of Berkshire’s stock portfolio at the end of September.</p><p><blockquote>尽管巴菲特在过去四个季度一直是净卖家，但与他庞大的股票投资组合规模相比，这些销售额相对较小。在过去的九个月里，他卖出的股票比买入的多了近70亿美元，约占伯克希尔9月底股票投资组合公允价值的2.2%。</blockquote></p><p> Buffett warned investors in May that Berkshire might not have much luck striking deals as SPACs gripped the market -- though he also predicted the boom probably wouldn’t last. Compounding the challenge, his most recent big acquisition, the $37 billion deal for Precision Castparts five years ago, resulted in a writedown that Buffett laid squarely at his own door.</p><p><blockquote>巴菲特在5月份警告投资者，随着SPAC席卷市场，伯克希尔哈撒韦公司在达成交易方面可能运气不佳，尽管他也预测这种繁荣可能不会持续下去。让挑战变得更加复杂的是，他最近的一次重大收购，即五年前以370亿美元收购Precision Castparts的交易，导致了巴菲特直接将其记入了自己的账户。</blockquote></p><p> Berkshire isn’t alone in extending a cash pile amid the pandemic. Amazon.com Inc., Google-parent Alphabet Inc. and American Airlines Group Inc. were among companies that amassed significant holdings during the health crisis in a step analysts have said would likely lead to some acquisitions.</p><p><blockquote>伯克希尔并不是唯一一家在疫情期间增加现金储备的公司。亚马逊公司、谷歌母公司Alphabet公司和美国航空集团公司等公司在健康危机期间增持了大量股份，分析师表示，此举可能会导致一些收购。</blockquote></p><p> And the rising cash pile is better than the alternative in the eyes of investors including Cheviot Value Management’s Darren Pollock. Even though Buffett’s cash pile still increased to a record despite the $7.6 billion of buybacks in the third quarter, Pollock says it’s a good sign about the health of Berkshire.</p><p><blockquote>在包括Cheviot Value Management的达伦·波洛克(Darren Pollock)在内的投资者看来，不断增加的现金储备比其他选择更好。尽管第三季度回购了76亿美元，但巴菲特的现金储备仍增至创纪录水平，波洛克表示，这是伯克希尔健康状况的一个好迹象。</blockquote></p><p> “We’re happy with it because the alternative is that cash isn’t growing as much and that means that Berkshire’s operating companies aren’t of as high quality as we thought,” said Pollock, whose Cheviot owns shares in Berkshire. “To see that the cash is rising, to see that he’s deploying so much in one avenue which happens to be buybacks -- it’s not acquisitions -- but it’s being spent in a productive way, it’s so much better than the alternative of seeing that cash stabilize or decline without other large acquisitions.”</p><p><blockquote>波洛克表示：“我们对此感到满意，因为另一种选择是现金没有增长那么多，这意味着伯克希尔哈撒韦公司的运营公司质量没有我们想象的那么高。”波洛克的切维奥特拥有伯克希尔哈撒韦公司的股份。“看到现金在增加，看到他在一个恰好是回购的途径上部署了如此多的资金——而不是收购——但这些资金是以富有成效的方式使用的，这比看到现金的替代方案要好得多如果没有其他大型收购，现金就会稳定或下降。”</blockquote></p><p> Here are some other key takeaways from Berkshire’s third-quarter earnings on Saturday:</p><p><blockquote>以下是伯克希尔周六第三季度财报的其他一些关键要点：</blockquote></p><p> Berkshire Appetite</p><p><blockquote>伯克希尔的胃口</blockquote></p><p> Buffett has increasingly leaned on share buybacks as one way to deploy billions of dollars. He’s spent about $51 billion on stock buybacks since a policy tweak in 2018, outpacing the $31 billion used to purchase shares of Apple Inc., Berkshire’s largest stock bet.</p><p><blockquote>巴菲特越来越依赖股票回购作为部署数十亿美元的一种方式。自2018年政策调整以来，伯克希尔在股票回购上花费了约510亿美元，超过了用于购买苹果股票的310亿美元，这是伯克希尔最大的股票赌注。</blockquote></p><p> In the third quarter, Berkshire bought back $7.6 billion of stock, surpassing the $6 billion of shares repurchased in the previous period.</p><p><blockquote>第三季度，伯克希尔回购了76亿美元的股票，超过了上一期回购的60亿美元股票。</blockquote></p><p> BNSF’s Record</p><p><blockquote>BNSF的记录</blockquote></p><p> Record profit at Berkshire’s railroad, BNSF, and strong earnings from its energy businesses helped raise operating profit by 18% at the conglomerate during the third quarter.</p><p><blockquote>伯克希尔旗下铁路公司BNSF创纪录的利润及其能源业务的强劲收益帮助该集团第三季度的营业利润提高了18%。</blockquote></p><p> That also aided in offsetting a painful quarter for Berkshire’s insurers. Those businesses reported an underwriting loss that widened to $784 million amid heightened catastrophe costs and worsening claims trends at auto insurer Geico.</p><p><blockquote>这也有助于抵消伯克希尔保险公司痛苦的季度。这些企业报告称，由于汽车保险公司Geico的灾难成本增加和索赔趋势恶化，承保损失扩大至7.84亿美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190184675","content_text":"(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.\nBuffett’s Berkshire Hathaway Inc. was a net seller of equities for the fourth straight quarter, a trend not seen in data going back to 2008. The company ended up selling almost $2 billion more in stocks than it purchased during the period, adding to a cash pile that climbed to a record $149.2 billion.\nThe selling streak indicates Buffett has struggled to find bargains with the stock market hitting all-time highs. A big, splashy acquisition also eluded the conglomerate, as the 91-year old and his investing deputies confronted a combination of sky-high price tags and fierce competition from the wave of special purpose acquisition companies.\n“The big issue here is that Berkshire was a net seller of stocks again this quarter,” Jim Shanahan, an analyst with Edward Jones, said in a telephone interview. “That’s the primary culprit” of the cash pile continuing to rise.\nBerkshire’s sales appear to have largely come from cutting holdings in banks, insurance and financial investments, according to its third-quarter regulatory filing released Saturday. Berkshire has been paring certain stocks in recent periods, spending the second quarter trimming its investment in General Motors Co. and pulling back on some of its pharmaceutical bets. The company is set to release its third-quarter stock tweaks later this month.\nWhile Buffett’s been a consistent net seller these past four quarters, those sales have been relatively small compared with the massive size of his stock portfolio. Over the past nine months, he’s sold almost $7 billion more of stocks than he’s bought, roughly 2.2% of the fair value of Berkshire’s stock portfolio at the end of September.\nBuffett warned investors in May that Berkshire might not have much luck striking deals as SPACs gripped the market -- though he also predicted the boom probably wouldn’t last. Compounding the challenge, his most recent big acquisition, the $37 billion deal for Precision Castparts five years ago, resulted in a writedown that Buffett laid squarely at his own door.\nBerkshire isn’t alone in extending a cash pile amid the pandemic. Amazon.com Inc., Google-parent Alphabet Inc. and American Airlines Group Inc. were among companies that amassed significant holdings during the health crisis in a step analysts have said would likely lead to some acquisitions.\nAnd the rising cash pile is better than the alternative in the eyes of investors including Cheviot Value Management’s Darren Pollock. Even though Buffett’s cash pile still increased to a record despite the $7.6 billion of buybacks in the third quarter, Pollock says it’s a good sign about the health of Berkshire.\n“We’re happy with it because the alternative is that cash isn’t growing as much and that means that Berkshire’s operating companies aren’t of as high quality as we thought,” said Pollock, whose Cheviot owns shares in Berkshire. “To see that the cash is rising, to see that he’s deploying so much in one avenue which happens to be buybacks -- it’s not acquisitions -- but it’s being spent in a productive way, it’s so much better than the alternative of seeing that cash stabilize or decline without other large acquisitions.”\nHere are some other key takeaways from Berkshire’s third-quarter earnings on Saturday:\nBerkshire Appetite\nBuffett has increasingly leaned on share buybacks as one way to deploy billions of dollars. He’s spent about $51 billion on stock buybacks since a policy tweak in 2018, outpacing the $31 billion used to purchase shares of Apple Inc., Berkshire’s largest stock bet.\nIn the third quarter, Berkshire bought back $7.6 billion of stock, surpassing the $6 billion of shares repurchased in the previous period.\nBNSF’s Record\nRecord profit at Berkshire’s railroad, BNSF, and strong earnings from its energy businesses helped raise operating profit by 18% at the conglomerate during the third quarter.\nThat also aided in offsetting a painful quarter for Berkshire’s insurers. Those businesses reported an underwriting loss that widened to $784 million amid heightened catastrophe costs and worsening claims trends at auto insurer Geico.","news_type":1,"symbols_score_info":{"BRK.B":0.9,"BRK.A":0.9}},"isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":600657865,"gmtCreate":1638150179895,"gmtModify":1638150179895,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600657865","repostId":"1114522326","repostType":4,"isVote":1,"tweetType":1,"viewCount":2887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878226325,"gmtCreate":1637199210060,"gmtModify":1637199210060,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878226325","repostId":"1180752156","repostType":4,"isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170061,"gmtCreate":1637628442357,"gmtModify":1637628442357,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875170061","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":1690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876175969,"gmtCreate":1637286640802,"gmtModify":1637286640802,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876175969","repostId":"1168345410","repostType":4,"isVote":1,"tweetType":1,"viewCount":1120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664166,"gmtCreate":1636939001730,"gmtModify":1636939001730,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay!","listText":"Okay!","text":"Okay!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664166","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846062060,"gmtCreate":1636035736976,"gmtModify":1636035737046,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"interesting","listText":"interesting","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846062060","repostId":"1168874793","repostType":4,"repost":{"id":"1168874793","kind":"news","pubTimestamp":1636035446,"share":"https://www.laohu8.com/m/news/1168874793?lang=zh_CN&edition=full","pubTime":"2021-11-04 22:17","market":"us","language":"en","title":"Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen：世卫组织批准科瓦克辛可能会转移投资者的注意力</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168874793","media":"Seeking Alpha","summary":"Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US ","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Ocugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.</li>  <li>Meanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.</li>  <li>There are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up &gt;4,000% in the past year, but has trodden water for several months.</li>  <li>It's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25648bf13e5cb82880f748129c72261c\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Klaus Vedfelt/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>今年早些时候，Ocugen错过了在美国获得科瓦克辛紧急使用授权的机会，但它仍然可以通过一项关键的免疫桥接研究获得批准。</li><li>与此同时，Bharat已获得世卫组织紧急使用清单批准，这意味着该疫苗可以在世界各地分发，但这并没有直接使Ocugen受益。</li><li>存在多种可能性，Ocugen并不缺乏支持者和空头——该股在过去一年中上涨了4,000%以上，但几个月来一直停滞不前。</li><li>很难确定Ocugen股东接下来会发生什么，但如果我是其中之一，我会持有并抱有希望。我在下面回顾了整个故事。</li></ul><p class=\"t-img-caption\"><span>Klaus Vedfelt/DigitalVision来自Getty Images</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> Bharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.</p><p><blockquote>巴拉特生物技术公司今天获得世界卫生组织（“世卫组织”）的批准，加入新冠肺炎疫苗的紧急使用清单（“EUL”）。</blockquote></p><p> As most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.</p><p><blockquote>正如大多数投资者所知，Ocugen(OCGN)拥有代表Bharat在美国分销科瓦克辛的权利，以换取所有利润45%的份额。它还为加拿大制定了类似的协议，将赚取所有利润的55%。</blockquote></p><p> Ocugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.</p><p><blockquote>Ocugen投资者和空头将紧张地等待，看看今天的消息如何影响该生物技术公司的股价，该公司的股价最初跃升至16美元，但盘后已跌至12美元。</blockquote></p><p> In this post I recap the full story, updated from my&nbsp;last post in June, and offer some ways to think about Ocugen's share price in the short and long term.</p><p><blockquote>在这篇文章中，我回顾了整个故事，更新了我6月份的上一篇文章，并提供了一些从短期和长期角度思考Ocugen股价的方法。</blockquote></p><p> <b>Ocugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far</b></p><p><blockquote><b>由于巴拉特新冠疫苗交易，Ocugen股价在3个月内从0.5美元上涨至16美元——迄今为止的故事</b></blockquote></p><p> Ocugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading &lt;$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").</p><p><blockquote>Ocugen是2021年更离奇的生物技术故事之一。2020年12月中旬，其股价交易价格&lt;0.5美元，因为该公司放弃了移植物抗宿主病（“GvHD”）主要候选药物OCU300的开发，难以开发针对眼病的基因治疗候选药物的临床前组合。</blockquote></p><p> A delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech&nbsp;became a partner&nbsp;of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.</p><p><blockquote>该公司可能会从纳斯达克退市，但随后Ocugen的命运发生了巨大变化——该生物技术公司成为全病毒体灭活疫苗候选物Covaxin开发商Bharat Biotech的合作伙伴，同意帮助这家印度制药公司将Covaxin商业化在美国和加拿大。一夜之间，Ocugen的股价跃升至3美元，到2月初，其交易价格为16美元。</blockquote></p><p> I covered the full story in a&nbsp;note on Ocugen&nbsp;back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.</p><p><blockquote>早在6月份，我就在一篇关于Ocugen的报告中报道了完整的故事，当时Ocugen的股价在6-10美元之间稍微实际一点的范围内交易。当时，关键问题是科瓦克辛是否会获得FDA的紧急使用授权（“EUA”），允许其在美国上市销售。</blockquote></p><p> Unfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.</p><p><blockquote>对于Ocugen投资者来说不幸的是，Bharat在印度的科瓦克辛病试验被推迟，印度的COVID疫情突然变得广泛，这意味着Ocugen无法在美国政府规定的最后期限前及时向FDA获得积极的3期试验数据——此后，对于那些尚未开始与FDA讨论的公司，它将不会接受任何进一步的EUA请求，为大流行的剩余时间提供COVID-19疫苗。</blockquote></p><p> <b>Ocugen And Bharat Stay The Course - Trials Reveal Strong Efficacy</b></p><p><blockquote><b>Ocugen和Bharat坚持到底——试验显示出强大的功效</b></blockquote></p><p> The bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.</p><p><blockquote>然而，有关美国EUA的坏消息并没有阻止Ocugen、Bharat或Ocugen的投资者。尽管空头兴趣浓厚，但许多市场观察人士得出的结论是，如果科瓦克辛在美国没有EUA，Ocugen的股价将大幅下跌，Ocugen管理层认为还有其他选择，包括在加拿大获得EUA，这属于其与Bharat的协议，使Ocugen能够赚取该地区所有收入的45%。</blockquote></p><p> The results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.</p><p><blockquote>Bharat在印度的~@5k患者3期试验结果也是积极的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/862520ed53c876fb96840a3cb9a7a6f9\" tg-width=\"640\" tg-height=\"317\" width=\"100%\" height=\"auto\"><span>Summary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.</span></p><p><blockquote><p class=\"t-img-caption\"><span>Bharat Biotech科瓦克辛病3期试验结果总结。资料来源：Ocugen公司介绍。</span></p></blockquote></p><p> As we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.</p><p><blockquote>正如我们在上面看到的，巴拉特的科瓦克辛（最终）提供了77.8%的功效读数，对严重疾病的功效为93.4%，对德尔塔变异毒株的功效为65.2%，这是所有新冠病毒株中最具破坏性的。此外，美国国家过敏和传染病研究所建议，在NIAID的支持下，在美国堪萨斯开发的一种新型疫苗佐剂Alhydroxiquim-II增强了科瓦克辛病的总体疗效。</blockquote></p><p> <b>Bharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada</b></p><p><blockquote><b>Bharat寻求世界卫生组织紧急使用清单，而Ocugen则将目光投向加拿大</b></blockquote></p><p></p><p> These results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has&nbsp;dropped as low as 39%&nbsp;in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.</p><p><blockquote>这些结果尽管很强——应该指出的是，辉瑞(PFE)和BioNTech(BNTX)信使RNA Comirnaty疫苗针对德尔塔变异毒株病毒的功效在以色列的研究中已下降至39%——但它们来得太晚了无法帮助Ocugen在美国获得EUA。</blockquote></p><p> Ocugen turned its attention to Canada,announcing&nbsp;a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd<b>,</b>allowing for it to submit new data as and when it came in, accelerating the overall review process.</p><p><blockquote>Ocugen将注意力转向加拿大，于7月15日宣布通过其附属公司Vaccigen，Ltd向加拿大卫生部提交滚动申请<b>,</b>允许it部门在收到新数据时提交新数据，从而加快整体审查过程。</blockquote></p><p> If approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my&nbsp;last note when providing some discounted cash flow analysis&nbsp;based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.</p><p><blockquote>如果获得批准，Ocugen将获得该疫苗所有利润的55%，但正如我在上一篇笔记中讨论的那样，在提供一些基于乐观和悲观情景的贴现现金流分析时，仅加拿大政府的购买是否会提供这一结果值得怀疑。Ocugen目前的市值估值为25亿美元，股价为12.7美元。</blockquote></p><p> The US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\")&nbsp;submission&nbsp;to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:</p><p><blockquote>美国是Ocugen的关键，管理层绝不会放弃这个机会。10月下旬，Ocugen向FDA提交了研究性新药（“IND”）。Ocugen的计划是启动一项3期“免疫桥接研究”，在美国招募数百名健康成年人，他们将接受2剂科瓦克辛或安慰剂，间隔28天。管理层（在10月27日的新闻稿中）对这些终点的描述如下：</blockquote></p><p>   The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population.  Ocugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.</p><p><blockquote>主要终点将比较从接受科瓦克辛的美国参与者身上采集的血液样本™在印度进行的3期疗效试验的参与者样本。次要终点包括测试疫苗的免疫原性特征。该研究还将评估美国人群的安全性和耐受性。如果FDA批准，Ocugen希望在H122结束前完成这项研究，但FDA尚未做出决定。如果FDA真的开了绿灯，那么美国市场——以及Ocugen 45%的利润——就会突然回到桌面上。</blockquote></p><p> Meanwhile, Bharat Biotech&nbsp;received notification&nbsp;today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.</p><p><blockquote>与此同时，Bharat Biotech今天收到通知，世界卫生组织已批准其紧急使用清单（“EUL”）的申请，这意味着科瓦克辛现在可能会被许多外国政府接受，接种疫苗的印度人出国旅行的问题将更少。</blockquote></p><p> It's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson &amp; Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.</p><p><blockquote>这对Bharat来说是个好消息，他与辉瑞/BioNTech、强生(JNJ)、国药控股、Moderna(MRNA)和阿斯利康(AZN)等公司一起加入了EUL批准的疫苗开发商名单，但这不一定是好消息对于Ocugen来说。</blockquote></p><p> Vaccines on the EUL list are permitted to be sent to government's around the world as part of the&nbsp;COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.</p><p><blockquote>作为COVAX计划的一部分，EUL清单上的疫苗被允许发送到世界各地的政府，该计划旨在在世界各地（包括较贫穷国家）实现公平的疫苗分配，但美国是该计划的捐助者，而不是受益者，这意味着由于世卫组织批准科瓦克辛，Ocugen实际上没有获得任何好处，也没有收入。</blockquote></p><p> <b>Ocugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA</b></p><p><blockquote><b>Ocugen股票已经处于下降趋势——现在所有人的目光都集中在加拿大卫生部和FDA身上</b></blockquote></p><p> Ocugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.</p><p><blockquote>Ocugen股票在今天的交易中从约9美元的价格反弹至约16美元的峰值，但股价很快开始下跌，最终收于12.7美元。盘后，股价又下跌10%。</blockquote></p><p> That reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.</p><p><blockquote>这反映出这样一个事实：世卫组织对科瓦克辛的批准对改善Ocugen自身的命运几乎没有什么作用，而且说实话，这有点转移视线。</blockquote></p><p> Ocugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.</p><p><blockquote>Ocugen投资者和Ocugen空头迫切想知道科瓦克辛在美国和加拿大的未来会怎样，但他们必须等到加拿大卫生部和FDA分别就紧急使用授权做出裁决，并批准开始在美国进行大幅减少的关键试验。</blockquote></p><p> Ironically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.</p><p><blockquote>具有讽刺意味的是，尽管有所有的新闻报道和科瓦克辛3期试验数据的公布，以及印度政府授予科瓦克辛的EUA，但Ocugen的命运与我上次报道该公司时相似——除了美国EUA的机会。</blockquote></p><p> That opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.</p><p><blockquote>这个机会——可能让Ocugen股价飙升的机会——已经过去了，但正如我在上一篇文章中所说，我认为美国可能不会反对储存一些科瓦克辛疫苗，它具有差异化的作用机制，如果储存在2-8摄氏度下，保质期可达数年。</blockquote></p><p> Covaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.</p><p><blockquote>理由可能是，科瓦克辛可能具有其他疫苗没有的好处，例如它能够诱导Th1反应，赋予细胞介导的免疫并提供持久的保护，以及增强对COVID变异的保护，这是目前主要关注的问题。</blockquote></p><p> On the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.</p><p><blockquote>另一方面，美国现在可能能够通过世卫组织直接从巴拉特获得供应，并能够将中间人Ocugen排除在任何交易之外。</blockquote></p><p></p><p> The fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.</p><p><blockquote>事实是，Ocugen与巴拉特和科瓦克辛的机会似乎总是需要权宜之计的执行，以便利用美国市场的机会，这种机会在最坏的情况下是不确定的，也许可以忽略不计，在最好的情况下是潜在的数十亿美元的机会。</blockquote></p><p> Nobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.</p><p><blockquote>没有人知道Ocugen是否有机会在美国销售科瓦克辛，但如果有机会，它将需要首先谈判一项棘手的3期试验，这可能会让我们进入明年下半年。同样，目前还没有人知道加拿大卫生部是否会批准该疫苗。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> To summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?</p><p><blockquote>总结一下目前的情况，我倾向于加拿大的批准——如果科瓦克辛对世卫组织来说足够好，为什么对加拿大来说不够好呢？</blockquote></p><p> But how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.</p><p><blockquote>但是加拿大会购买多少产品呢？这可能足以导致Ocugen股票的价格大幅飙升，尽管需求不太可能高到足以长期维持这种飙升。</blockquote></p><p> How much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.</p><p><blockquote>如果科瓦克辛在美国获得批准，美国会买多少？再说一次，我认为这个交易量不足以将Ocugen的市值推高到100亿美元以上，但如果它真的购买任何股票，Ocugen的市值或多或少肯定会飙升，至少是暂时的。</blockquote></p><p> In conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.</p><p><blockquote>总之，我认为Ocugen的故事中有足够的阴谋和机会让投资者保持兴趣——无论是空头还是多头。世界卫生组织的批准并没有直接有利于Ocugen的收入，但这是科瓦克辛的又一次胜利，这反过来也是Ocugen的胜利。</blockquote></p><p> If I has been holding Ocugen stock since December last year, when it traded at &gt;$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.</p><p><blockquote>如果我自去年12月以来一直持有Ocugen股票，当时其交易价格&gt;0.5美元，坦率地说，我现在就会卖出，但如果我以约10美元的价格建仓，期望在美国批准后我的资金翻倍，我仍然会（紧张地）持有。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen：世卫组织批准科瓦克辛可能会转移投资者的注意力</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors<blockquote>Ocugen：世卫组织批准科瓦克辛可能会转移投资者的注意力</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-11-04 22:17</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Ocugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.</li>  <li>Meanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.</li>  <li>There are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up &gt;4,000% in the past year, but has trodden water for several months.</li>  <li>It's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25648bf13e5cb82880f748129c72261c\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Klaus Vedfelt/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>今年早些时候，Ocugen错过了在美国获得科瓦克辛紧急使用授权的机会，但它仍然可以通过一项关键的免疫桥接研究获得批准。</li><li>与此同时，Bharat已获得世卫组织紧急使用清单批准，这意味着该疫苗可以在世界各地分发，但这并没有直接使Ocugen受益。</li><li>存在多种可能性，Ocugen并不缺乏支持者和空头——该股在过去一年中上涨了4,000%以上，但几个月来一直停滞不前。</li><li>很难确定Ocugen股东接下来会发生什么，但如果我是其中之一，我会持有并抱有希望。我在下面回顾了整个故事。</li></ul><p class=\"t-img-caption\"><span>Klaus Vedfelt/DigitalVision来自Getty Images</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> Bharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.</p><p><blockquote>巴拉特生物技术公司今天获得世界卫生组织（“世卫组织”）的批准，加入新冠肺炎疫苗的紧急使用清单（“EUL”）。</blockquote></p><p> As most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.</p><p><blockquote>正如大多数投资者所知，Ocugen(OCGN)拥有代表Bharat在美国分销科瓦克辛的权利，以换取所有利润45%的份额。它还为加拿大制定了类似的协议，将赚取所有利润的55%。</blockquote></p><p> Ocugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.</p><p><blockquote>Ocugen投资者和空头将紧张地等待，看看今天的消息如何影响该生物技术公司的股价，该公司的股价最初跃升至16美元，但盘后已跌至12美元。</blockquote></p><p> In this post I recap the full story, updated from my&nbsp;last post in June, and offer some ways to think about Ocugen's share price in the short and long term.</p><p><blockquote>在这篇文章中，我回顾了整个故事，更新了我6月份的上一篇文章，并提供了一些从短期和长期角度思考Ocugen股价的方法。</blockquote></p><p> <b>Ocugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far</b></p><p><blockquote><b>由于巴拉特新冠疫苗交易，Ocugen股价在3个月内从0.5美元上涨至16美元——迄今为止的故事</b></blockquote></p><p> Ocugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading &lt;$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").</p><p><blockquote>Ocugen是2021年更离奇的生物技术故事之一。2020年12月中旬，其股价交易价格&lt;0.5美元，因为该公司放弃了移植物抗宿主病（“GvHD”）主要候选药物OCU300的开发，难以开发针对眼病的基因治疗候选药物的临床前组合。</blockquote></p><p> A delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech&nbsp;became a partner&nbsp;of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.</p><p><blockquote>该公司可能会从纳斯达克退市，但随后Ocugen的命运发生了巨大变化——该生物技术公司成为全病毒体灭活疫苗候选物Covaxin开发商Bharat Biotech的合作伙伴，同意帮助这家印度制药公司将Covaxin商业化在美国和加拿大。一夜之间，Ocugen的股价跃升至3美元，到2月初，其交易价格为16美元。</blockquote></p><p> I covered the full story in a&nbsp;note on Ocugen&nbsp;back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.</p><p><blockquote>早在6月份，我就在一篇关于Ocugen的报告中报道了完整的故事，当时Ocugen的股价在6-10美元之间稍微实际一点的范围内交易。当时，关键问题是科瓦克辛是否会获得FDA的紧急使用授权（“EUA”），允许其在美国上市销售。</blockquote></p><p> Unfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.</p><p><blockquote>对于Ocugen投资者来说不幸的是，Bharat在印度的科瓦克辛病试验被推迟，印度的COVID疫情突然变得广泛，这意味着Ocugen无法在美国政府规定的最后期限前及时向FDA获得积极的3期试验数据——此后，对于那些尚未开始与FDA讨论的公司，它将不会接受任何进一步的EUA请求，为大流行的剩余时间提供COVID-19疫苗。</blockquote></p><p> <b>Ocugen And Bharat Stay The Course - Trials Reveal Strong Efficacy</b></p><p><blockquote><b>Ocugen和Bharat坚持到底——试验显示出强大的功效</b></blockquote></p><p> The bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.</p><p><blockquote>然而，有关美国EUA的坏消息并没有阻止Ocugen、Bharat或Ocugen的投资者。尽管空头兴趣浓厚，但许多市场观察人士得出的结论是，如果科瓦克辛在美国没有EUA，Ocugen的股价将大幅下跌，Ocugen管理层认为还有其他选择，包括在加拿大获得EUA，这属于其与Bharat的协议，使Ocugen能够赚取该地区所有收入的45%。</blockquote></p><p> The results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.</p><p><blockquote>Bharat在印度的~@5k患者3期试验结果也是积极的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/862520ed53c876fb96840a3cb9a7a6f9\" tg-width=\"640\" tg-height=\"317\" width=\"100%\" height=\"auto\"><span>Summary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.</span></p><p><blockquote><p class=\"t-img-caption\"><span>Bharat Biotech科瓦克辛病3期试验结果总结。资料来源：Ocugen公司介绍。</span></p></blockquote></p><p> As we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.</p><p><blockquote>正如我们在上面看到的，巴拉特的科瓦克辛（最终）提供了77.8%的功效读数，对严重疾病的功效为93.4%，对德尔塔变异毒株的功效为65.2%，这是所有新冠病毒株中最具破坏性的。此外，美国国家过敏和传染病研究所建议，在NIAID的支持下，在美国堪萨斯开发的一种新型疫苗佐剂Alhydroxiquim-II增强了科瓦克辛病的总体疗效。</blockquote></p><p> <b>Bharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada</b></p><p><blockquote><b>Bharat寻求世界卫生组织紧急使用清单，而Ocugen则将目光投向加拿大</b></blockquote></p><p></p><p> These results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has&nbsp;dropped as low as 39%&nbsp;in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.</p><p><blockquote>这些结果尽管很强——应该指出的是，辉瑞(PFE)和BioNTech(BNTX)信使RNA Comirnaty疫苗针对德尔塔变异毒株病毒的功效在以色列的研究中已下降至39%——但它们来得太晚了无法帮助Ocugen在美国获得EUA。</blockquote></p><p> Ocugen turned its attention to Canada,announcing&nbsp;a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd<b>,</b>allowing for it to submit new data as and when it came in, accelerating the overall review process.</p><p><blockquote>Ocugen将注意力转向加拿大，于7月15日宣布通过其附属公司Vaccigen，Ltd向加拿大卫生部提交滚动申请<b>,</b>允许it部门在收到新数据时提交新数据，从而加快整体审查过程。</blockquote></p><p> If approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my&nbsp;last note when providing some discounted cash flow analysis&nbsp;based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.</p><p><blockquote>如果获得批准，Ocugen将获得该疫苗所有利润的55%，但正如我在上一篇笔记中讨论的那样，在提供一些基于乐观和悲观情景的贴现现金流分析时，仅加拿大政府的购买是否会提供这一结果值得怀疑。Ocugen目前的市值估值为25亿美元，股价为12.7美元。</blockquote></p><p> The US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\")&nbsp;submission&nbsp;to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:</p><p><blockquote>美国是Ocugen的关键，管理层绝不会放弃这个机会。10月下旬，Ocugen向FDA提交了研究性新药（“IND”）。Ocugen的计划是启动一项3期“免疫桥接研究”，在美国招募数百名健康成年人，他们将接受2剂科瓦克辛或安慰剂，间隔28天。管理层（在10月27日的新闻稿中）对这些终点的描述如下：</blockquote></p><p>   The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population.  Ocugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.</p><p><blockquote>主要终点将比较从接受科瓦克辛的美国参与者身上采集的血液样本™在印度进行的3期疗效试验的参与者样本。次要终点包括测试疫苗的免疫原性特征。该研究还将评估美国人群的安全性和耐受性。如果FDA批准，Ocugen希望在H122结束前完成这项研究，但FDA尚未做出决定。如果FDA真的开了绿灯，那么美国市场——以及Ocugen 45%的利润——就会突然回到桌面上。</blockquote></p><p> Meanwhile, Bharat Biotech&nbsp;received notification&nbsp;today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.</p><p><blockquote>与此同时，Bharat Biotech今天收到通知，世界卫生组织已批准其紧急使用清单（“EUL”）的申请，这意味着科瓦克辛现在可能会被许多外国政府接受，接种疫苗的印度人出国旅行的问题将更少。</blockquote></p><p> It's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson &amp; Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.</p><p><blockquote>这对Bharat来说是个好消息，他与辉瑞/BioNTech、强生(JNJ)、国药控股、Moderna(MRNA)和阿斯利康(AZN)等公司一起加入了EUL批准的疫苗开发商名单，但这不一定是好消息对于Ocugen来说。</blockquote></p><p> Vaccines on the EUL list are permitted to be sent to government's around the world as part of the&nbsp;COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.</p><p><blockquote>作为COVAX计划的一部分，EUL清单上的疫苗被允许发送到世界各地的政府，该计划旨在在世界各地（包括较贫穷国家）实现公平的疫苗分配，但美国是该计划的捐助者，而不是受益者，这意味着由于世卫组织批准科瓦克辛，Ocugen实际上没有获得任何好处，也没有收入。</blockquote></p><p> <b>Ocugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA</b></p><p><blockquote><b>Ocugen股票已经处于下降趋势——现在所有人的目光都集中在加拿大卫生部和FDA身上</b></blockquote></p><p> Ocugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.</p><p><blockquote>Ocugen股票在今天的交易中从约9美元的价格反弹至约16美元的峰值，但股价很快开始下跌，最终收于12.7美元。盘后，股价又下跌10%。</blockquote></p><p> That reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.</p><p><blockquote>这反映出这样一个事实：世卫组织对科瓦克辛的批准对改善Ocugen自身的命运几乎没有什么作用，而且说实话，这有点转移视线。</blockquote></p><p> Ocugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.</p><p><blockquote>Ocugen投资者和Ocugen空头迫切想知道科瓦克辛在美国和加拿大的未来会怎样，但他们必须等到加拿大卫生部和FDA分别就紧急使用授权做出裁决，并批准开始在美国进行大幅减少的关键试验。</blockquote></p><p> Ironically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.</p><p><blockquote>具有讽刺意味的是，尽管有所有的新闻报道和科瓦克辛3期试验数据的公布，以及印度政府授予科瓦克辛的EUA，但Ocugen的命运与我上次报道该公司时相似——除了美国EUA的机会。</blockquote></p><p> That opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.</p><p><blockquote>这个机会——可能让Ocugen股价飙升的机会——已经过去了，但正如我在上一篇文章中所说，我认为美国可能不会反对储存一些科瓦克辛疫苗，它具有差异化的作用机制，如果储存在2-8摄氏度下，保质期可达数年。</blockquote></p><p> Covaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.</p><p><blockquote>理由可能是，科瓦克辛可能具有其他疫苗没有的好处，例如它能够诱导Th1反应，赋予细胞介导的免疫并提供持久的保护，以及增强对COVID变异的保护，这是目前主要关注的问题。</blockquote></p><p> On the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.</p><p><blockquote>另一方面，美国现在可能能够通过世卫组织直接从巴拉特获得供应，并能够将中间人Ocugen排除在任何交易之外。</blockquote></p><p></p><p> The fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.</p><p><blockquote>事实是，Ocugen与巴拉特和科瓦克辛的机会似乎总是需要权宜之计的执行，以便利用美国市场的机会，这种机会在最坏的情况下是不确定的，也许可以忽略不计，在最好的情况下是潜在的数十亿美元的机会。</blockquote></p><p> Nobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.</p><p><blockquote>没有人知道Ocugen是否有机会在美国销售科瓦克辛，但如果有机会，它将需要首先谈判一项棘手的3期试验，这可能会让我们进入明年下半年。同样，目前还没有人知道加拿大卫生部是否会批准该疫苗。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> To summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?</p><p><blockquote>总结一下目前的情况，我倾向于加拿大的批准——如果科瓦克辛对世卫组织来说足够好，为什么对加拿大来说不够好呢？</blockquote></p><p> But how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.</p><p><blockquote>但是加拿大会购买多少产品呢？这可能足以导致Ocugen股票的价格大幅飙升，尽管需求不太可能高到足以长期维持这种飙升。</blockquote></p><p> How much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.</p><p><blockquote>如果科瓦克辛在美国获得批准，美国会买多少？再说一次，我认为这个交易量不足以将Ocugen的市值推高到100亿美元以上，但如果它真的购买任何股票，Ocugen的市值或多或少肯定会飙升，至少是暂时的。</blockquote></p><p> In conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.</p><p><blockquote>总之，我认为Ocugen的故事中有足够的阴谋和机会让投资者保持兴趣——无论是空头还是多头。世界卫生组织的批准并没有直接有利于Ocugen的收入，但这是科瓦克辛的又一次胜利，这反过来也是Ocugen的胜利。</blockquote></p><p> If I has been holding Ocugen stock since December last year, when it traded at &gt;$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.</p><p><blockquote>如果我自去年12月以来一直持有Ocugen股票，当时其交易价格&gt;0.5美元，坦率地说，我现在就会卖出，但如果我以约10美元的价格建仓，期望在美国批准后我的资金翻倍，我仍然会（紧张地）持有。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168874793","content_text":"Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.\nMeanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.\nThere are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up >4,000% in the past year, but has trodden water for several months.\nIt's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.\n\nKlaus Vedfelt/DigitalVision via Getty Images\nInvestment Thesis\nBharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.\nAs most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.\nOcugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.\nIn this post I recap the full story, updated from my last post in June, and offer some ways to think about Ocugen's share price in the short and long term.\nOcugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far\nOcugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading <$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").\nA delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech became a partner of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.\nI covered the full story in a note on Ocugen back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.\nUnfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.\nOcugen And Bharat Stay The Course - Trials Reveal Strong Efficacy\nThe bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.\nThe results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.\nSummary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.\nAs we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.\nBharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada\nThese results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has dropped as low as 39% in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.\nOcugen turned its attention to Canada,announcing a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd,allowing for it to submit new data as and when it came in, accelerating the overall review process.\nIf approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my last note when providing some discounted cash flow analysis based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.\nThe US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\") submission to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:\n\n The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population.\n\nOcugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.\nMeanwhile, Bharat Biotech received notification today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.\nIt's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson & Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.\nVaccines on the EUL list are permitted to be sent to government's around the world as part of the COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.\nOcugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA\nOcugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.\nThat reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.\nOcugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.\nIronically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.\nThat opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.\nCovaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.\nOn the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.\nThe fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.\nNobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.\nConclusion\nTo summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?\nBut how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.\nHow much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.\nIn conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.\nIf I has been holding Ocugen stock since December last year, when it traded at >$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":643,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690069678,"gmtCreate":1639614219904,"gmtModify":1639614219904,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690069678","repostId":"1194155872","repostType":4,"repost":{"id":"1194155872","kind":"news","pubTimestamp":1639613035,"share":"https://www.laohu8.com/m/news/1194155872?lang=zh_CN&edition=full","pubTime":"2021-12-16 08:03","market":"us","language":"en","title":"Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194155872","media":"RTTNews","summary":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day sli","content":"<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次下跌，此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于3,115点的高位，尽管预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>在FOMC货币政策会议结果公布后，全球对亚洲市场的预测乐观。欧洲和美国市场稳步走高，亚洲股市预计也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>在房地产和工业股下跌后，海指周三小幅收低，而金融股则涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天，该指数在3,106.63点至3,120.55点之间交易后，下跌6.21点或0.20%，收于3,114.88点。成交量为8.834亿股，价值7.618亿新元。下跌股264家，上涨股180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌0.34%，凯德综合商业信托下跌0.50%，City Developments下跌0.42%，Comfort DelGro上涨1.45%，Dairy Farm International暴跌2.42%，星展集团上涨0.19%，云顶新加坡退保0.64%，吉宝企业下跌0.39%，丰树商业信托下跌0.98%，丰树物流信托下跌0.53%，华侨银行下跌0.27%，胜科工业下跌0.51%，新加坡航空下跌0.20%，新加坡电信下跌0.41%，泰国饮料下跌0.75%，大华银行下跌0.15%，丰益国际下跌0.96%，扬子江造船、新加坡报业控股、新加坡科技工程和新天科技持平。</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的，主要股指周三开盘小幅走低，但随后下午飙升，收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&amp;P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点，涨幅1.08%，收于35,927.43点；纳斯达克指数飙升327.94点，涨幅2.15%，收于15,565.58点；标普500指数上涨75.76点，涨幅1.63%，收于4,709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>在美联储宣布了人们普遍预期的加快缩减资产购买计划步伐的决定后，华尔街尾盘上涨。美联储以通胀发展和劳动力市场进一步改善为由表示，已决定将净资产购买速度每月减少300亿美元，是此前宣布的每月150亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示，预计每个月净资产购买速度的类似减少可能是适当的，这表明该计划将于明年3月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时，美联储还宣布了广泛预期的决定，将联邦基金利率目标区间维持在零至0.25%。与9月份的一次加息预测相比，央行的最新预测2022年将加息多达三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息时间可能早于预期，但分析师表示，交易员对美联储最新预测提供的确定性水平提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署（EIA）表示，上周美国原油库存减少460万桶，原油期货周三收高。西德克萨斯中质原油1月期货收涨0.14美元或0.2%，报每桶70.87美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market<blockquote>新加坡股市有望反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-16 08:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p><p><blockquote>新加坡股市周三再次下跌，此前一个交易日结束了连续两天下跌超过20点或0.7%的下跌。海峡时报指数目前略低于3,115点的高位，尽管预计周四将再次反弹。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p><p><blockquote>在FOMC货币政策会议结果公布后，全球对亚洲市场的预测乐观。欧洲和美国市场稳步走高，亚洲股市预计也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p><p><blockquote>在房地产和工业股下跌后，海指周三小幅收低，而金融股则涨跌互现。</blockquote></p><p> For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p><p><blockquote>当天，该指数在3,106.63点至3,120.55点之间交易后，下跌6.21点或0.20%，收于3,114.88点。成交量为8.834亿股，价值7.618亿新元。下跌股264家，上涨股180家。</blockquote></p><p> Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托下跌0.34%，凯德综合商业信托下跌0.50%，City Developments下跌0.42%，Comfort DelGro上涨1.45%，Dairy Farm International暴跌2.42%，星展集团上涨0.19%，云顶新加坡退保0.64%，吉宝企业下跌0.39%，丰树商业信托下跌0.98%，丰树物流信托下跌0.53%，华侨银行下跌0.27%，胜科工业下跌0.51%，新加坡航空下跌0.20%，新加坡电信下跌0.41%，泰国饮料下跌0.75%，大华银行下跌0.15%，丰益国际下跌0.96%，扬子江造船、新加坡报业控股、新加坡科技工程和新天科技持平。</blockquote></p><p> The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p><p><blockquote>华尔街的领先优势总体上是积极的，主要股指周三开盘小幅走低，但随后下午飙升，收盘大幅走高。</blockquote></p><p> The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&amp;P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p><p><blockquote>道琼斯指数飙升383.25点，涨幅1.08%，收于35,927.43点；纳斯达克指数飙升327.94点，涨幅2.15%，收于15,565.58点；标普500指数上涨75.76点，涨幅1.63%，收于4,709.85点。</blockquote></p><p> The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p><p><blockquote>在美联储宣布了人们普遍预期的加快缩减资产购买计划步伐的决定后，华尔街尾盘上涨。美联储以通胀发展和劳动力市场进一步改善为由表示，已决定将净资产购买速度每月减少300亿美元，是此前宣布的每月150亿美元的两倍。</blockquote></p><p> The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p><p><blockquote>美联储表示，预计每个月净资产购买速度的类似减少可能是适当的，这表明该计划将于明年3月结束。分析师将随后的反弹部分归因于美联储没有更积极地加快停止资产购买的时间表。</blockquote></p><p> Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p><p><blockquote>与此同时，美联储还宣布了广泛预期的决定，将联邦基金利率目标区间维持在零至0.25%。与9月份的一次加息预测相比，央行的最新预测2022年将加息多达三次。</blockquote></p><p> Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p><p><blockquote>尽管加息时间可能早于预期，但分析师表示，交易员对美联储最新预测提供的确定性水平提高感到满意。</blockquote></p><p> Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p><p><blockquote>美国能源信息署（EIA）表示，上周美国原油库存减少460万桶，原油期货周三收高。西德克萨斯中质原油1月期货收涨0.14美元或0.2%，报每桶70.87美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194155872","content_text":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.\nThe global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.\nThe STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.\nFor the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.\nAmong the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.\nThe lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.\nThe Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.\nThe late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.\nThe Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.\nMeanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.\nDespite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":4177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872766499,"gmtCreate":1637576322119,"gmtModify":1637576322119,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872766499","repostId":"2185826772","repostType":4,"isVote":1,"tweetType":1,"viewCount":1014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847697615,"gmtCreate":1636511453772,"gmtModify":1636511453902,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay&nbsp;","listText":"okay&nbsp;","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847697615","repostId":"1179672442","repostType":4,"isVote":1,"tweetType":1,"viewCount":728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871759657,"gmtCreate":1637115093499,"gmtModify":1637115101793,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871759657","repostId":"1185179037","repostType":4,"isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}